"","name","centrality","Category","centralPercent"
"1","2-LTR circle formation",0,"Pathway",1
"2","3' -UTR-mediated translational regulation",0,"Pathway",1
"3","A tetrasaccharide linker sequence is required for GAG synthesis",0,"Pathway",1
"4","A third proteolytic cleavage releases NICD",0,"Pathway",1
"5","a6b1 and a6b4 Integrin signaling",0,"Pathway",1
"6","Abacavir transmembrane transport",0,"Pathway",1
"7","Abacavir transport and metabolism",0,"Pathway",1
"8","ABC-family proteins mediated transport",0,"Pathway",1
"9","ABCB1",13,"Gene",92
"10","ABCC5",10,"Gene",91
"11","ABCF3",0,"Gene",1
"12","ABHD6",0,"Gene",1
"13","Abnormal metabolism in phenylketonuria",0,"Pathway",1
"14","ACAT2",0,"Gene",1
"15","Acetylcholine Binding And Downstream Events",0,"Pathway",1
"16","Acetylcholine Neurotransmitter Release Cycle",0,"Pathway",1
"17","Acetylcholine regulates insulin secretion",0,"Pathway",1
"18","ACOT9",0,"Gene",1
"19","Activated NOTCH1 Transmits Signal to the Nucleus",0,"Pathway",1
"20","Activated point mutants of FGFR2",0,"Pathway",1
"21","activated TAK1 mediates p38 MAPK activation",0,"Pathway",1
"22","Activated TLR4 signalling",0,"Pathway",2
"23","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins",0,"Pathway",2
"24","Activation of ATR in response to replication stress",0,"Pathway",2
"25","Activation of BAD and translocation to mitochondria",0,"Pathway",2
"26","Activation of BH3-only proteins",0,"Pathway",2
"27","Activation of caspases through apoptosome-mediated cleavage",0,"Pathway",2
"28","Activation of GABAB receptors",0,"Pathway",2
"29","Activation of gene expression by SREBF (SREBP)",0,"Pathway",2
"30","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon",0,"Pathway",2
"31","Activation of Matrix Metalloproteinases",0,"Pathway",2
"32","Activation of NF-kappaB in B cells",0,"Pathway",2
"33","Activation of PKB",0,"Pathway",2
"34","Activation of PPARGC1A (PGC-1alpha) by phosphorylation",0,"Pathway",2
"35","Activation of Rac",0,"Pathway",2
"36","Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0,"Pathway",2
"37","Activation of the pre-replicative complex",0,"Pathway",2
"38","Activation, translocation and oligomerization of BAX",0,"Pathway",2
"39","Acyl chain remodeling of DAG and TAG",0,"Pathway",2
"40","ADAM10",28,"Gene",97
"41","Adaptive Immune System",0,"Pathway",2
"42","Adenylate cyclase inhibitory pathway",0,"Pathway",3
"43","ADGRE5",5,"Gene",84
"44","Adherens junctions interactions",0,"Pathway",3
"45","ADI1",5,"Gene",84
"46","Adipogenesis",0,"Pathway",3
"47","ADM",9,"Gene",90
"48","ADO",0,"Gene",3
"49","ADP signalling through P2Y purinoceptor 12",0,"Pathway",3
"50","ADRA1A",15,"Gene",94
"51","ADRA1B",15,"Gene",94
"52","ADRA1D",14,"Gene",93
"53","ADRA2A",19,"Gene",95
"54","ADRA2B",15,"Gene",94
"55","ADRA2C",19,"Gene",95
"56","Adrenaline signalling through Alpha-2 adrenergic receptor",0,"Pathway",3
"57","Adrenaline,noradrenaline inhibits insulin secretion",0,"Pathway",3
"58","Adrenoceptors",0,"Pathway",3
"59","ADSL",5,"Gene",84
"60","Advanced glycosylation endproduct receptor signaling",0,"Pathway",3
"61","AFF1",0,"Gene",3
"62","Aflatoxin activation and detoxification",0,"Pathway",3
"63","Aflatoxin B1 metabolism",0,"Pathway",3
"64","AGE/RAGE pathway",0,"Pathway",3
"65","AKR1B10",5,"Gene",84
"66","AKR7A2",5,"Gene",84
"67","AKT phosphorylates targets in the nucleus",0,"Pathway",3
"68","ALB",21,"Gene",96
"69","ALDOC",7,"Gene",87
"70","Allograft Rejection",0,"Pathway",3
"71","alpha-linolenic (omega3) and linoleic (omega6) acid metabolism",0,"Pathway",3
"72","Alpha-synuclein signaling",0,"Pathway",3
"73","Alpha 6 Beta 4 signaling pathway",0,"Pathway",3
"74","Alpha4 beta1 integrin signaling events",0,"Pathway",3
"75","Alpha6 beta4 integrin-ligand interactions",0,"Pathway",4
"76","AlphaE beta7 integrin cell surface interactions",0,"Pathway",4
"77","Alternative NF-kappaB pathway",0,"Pathway",4
"78","Alzheimers Disease",0,"Pathway",4
"79","amb2 Integrin signaling",0,"Pathway",4
"80","AMER1 mutants destabilize the destruction complex",0,"Pathway",4
"81","AMFR",1,"Gene",78
"82","Amine compound SLC transporters",0,"Pathway",4
"83","Amine ligand-binding receptors",0,"Pathway",4
"84","Amino acid and derivative metabolism",0,"Pathway",4
"85","Amino acid and oligopeptide SLC transporters",0,"Pathway",4
"86","Amino acid synthesis and interconversion (transamination)",0,"Pathway",4
"87","Amino acid transport across the plasma membrane",0,"Pathway",4
"88","AMPK inhibits chREBP transcriptional activation activity",0,"Pathway",4
"89","AMPK Signaling",0,"Pathway",4
"90","Amyloids",0,"Pathway",4
"91","Amyotrophic lateral sclerosis (ALS)",0,"Pathway",4
"92","Anchoring fibril formation",0,"Pathway",4
"93","Androgen receptor signaling pathway",0,"Pathway",4
"94","Angiopoietin receptor Tie2-mediated signaling",0,"Pathway",4
"95","ANKRD17",0,"Gene",5
"96","ANKS1A",0,"Gene",5
"97","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers",0,"Pathway",5
"98","Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0,"Pathway",5
"99","Antigen processing-Cross presentation",0,"Pathway",5
"100","Antigen processing: Ubiquitination & Proteasome degradation",0,"Pathway",5
"101","Antiviral mechanism by IFN-stimulated genes",0,"Pathway",5
"102","ANXA4",1,"Gene",78
"103","AP-1 transcription factor network",0,"Pathway",5
"104","AP2S1",35,"Gene",98
"105","APAF1",21,"Gene",96
"106","APC-Cdc20 mediated degradation of Nek2A",0,"Pathway",5
"107","APC/C-mediated degradation of cell cycle proteins",0,"Pathway",5
"108","APC/C:Cdc20 mediated degradation of Cyclin B",0,"Pathway",5
"109","APC/C:Cdc20 mediated degradation of mitotic proteins",0,"Pathway",5
"110","APC/C:Cdc20 mediated degradation of Securin",0,"Pathway",5
"111","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1",0,"Pathway",5
"112","APEX1",32,"Gene",98
"113","APLP2",0,"Gene",5
"114","APOBEC3G mediated resistance to HIV-1 infection",0,"Pathway",5
"115","Apoptosis",0,"Pathway",5
"116","Apoptosis",0,"Pathway",5
"117","Apoptosis",0,"Pathway",5
"118","Apoptosis",0,"Pathway",6
"119","Apoptosis-related network due to altered Notch3 in ovarian cancer",0,"Pathway",6
"120","Apoptosis Modulation and Signaling",0,"Pathway",6
"121","Apoptosis Modulation by HSP70",0,"Pathway",6
"122","Apoptotic cleavage of cell adhesion proteins",0,"Pathway",6
"123","Apoptotic cleavage of cellular proteins",0,"Pathway",6
"124","Apoptotic execution phase",0,"Pathway",6
"125","Apoptotic factor-mediated response",0,"Pathway",6
"126","APP",48,"Gene",99
"127","APPL1",5,"Gene",84
"128","APRT",4,"Gene",82
"129","Aquaporin-mediated transport",0,"Pathway",6
"130","Arachidonate Epoxygenase / Epoxide Hydrolase",0,"Pathway",6
"131","Arachidonic acid metabolism",0,"Pathway",6
"132","Arf6 downstream pathway",0,"Pathway",6
"133","Arf6 signaling events",0,"Pathway",6
"134","Arf6 trafficking events",0,"Pathway",6
"135","ARID4A",2,"Gene",79
"136","ARMS-mediated activation",0,"Pathway",6
"137","Arrhythmogenic Right Ventricular Cardiomyopathy",0,"Pathway",6
"138","Aryl Hydrocarbon Receptor",0,"Pathway",6
"139","Aryl Hydrocarbon Receptor Pathway",0,"Pathway",6
"140","Arylamine metabolism",0,"Pathway",6
"141","Asparagine N-linked glycosylation",0,"Pathway",7
"142","Assembly of collagen fibrils and other multimeric structures",0,"Pathway",7
"143","Assembly Of The HIV Virion",0,"Pathway",7
"144","Assembly of the pre-replicative complex",0,"Pathway",7
"145","Assembly of the RAD51-ssDNA nucleoprotein complex",0,"Pathway",7
"146","Association of licensing factors with the pre-replicative complex",0,"Pathway",7
"147","Association of TriC/CCT with target proteins during biosynthesis",0,"Pathway",7
"148","Astrocytic Glutamate-Glutamine Uptake And Metabolism",0,"Pathway",7
"149","ASUN",0,"Gene",7
"150","Asymmetric localization of PCP proteins",0,"Pathway",7
"151","ATF-2 transcription factor network",0,"Pathway",7
"152","ATF6-alpha activates chaperones",0,"Pathway",7
"153","ATG3",1,"Gene",78
"154","ATM Signaling Pathway",0,"Pathway",7
"155","ATP1B1",7,"Gene",87
"156","ATP6V0B",8,"Gene",89
"157","ATP6V1D",8,"Gene",89
"158","ATR signaling pathway",0,"Pathway",7
"159","ATRN",0,"Gene",7
"160","Attenuation phase",0,"Pathway",7
"161","Atypical NF-kappaB pathway",0,"Pathway",7
"162","AUF1 (hnRNP D0) destabilizes mRNA",0,"Pathway",7
"163","AURKB",16,"Gene",95
"164","Aurora A signaling",0,"Pathway",7
"165","Aurora B signaling",0,"Pathway",8
"166","Aurora C signaling",0,"Pathway",8
"167","Autodegradation of Cdh1 by Cdh1:APC/C",0,"Pathway",8
"168","Autodegradation of the E3 ubiquitin ligase COP1",0,"Pathway",8
"169","Autointegration results in viral DNA circles",0,"Pathway",8
"170","Axon guidance",0,"Pathway",8
"171","B Cell Activation",0,"Pathway",8
"172","B Cell Receptor Signaling Pathway",0,"Pathway",8
"173","B3GALNT1",1,"Gene",78
"174","BABAM1",0,"Gene",8
"175","BAG3",1,"Gene",78
"176","BANF1",21,"Gene",96
"177","BARD1 signaling events",0,"Pathway",8
"178","Base-Excision Repair, AP Site Formation",0,"Pathway",8
"179","Base-free sugar-phosphate removal via the single-nucleotide replacement pathway",0,"Pathway",8
"180","Base Excision Repair",0,"Pathway",8
"181","Basigin interactions",0,"Pathway",8
"182","BAX",28,"Gene",97
"183","BCAP31",3,"Gene",81
"184","BCL2",43,"Gene",99
"185","BCR signaling pathway",0,"Pathway",8
"186","BCS1L",2,"Gene",79
"187","BDNF signaling pathway",0,"Pathway",8
"188","Benzo(a)pyrene metabolism",0,"Pathway",8
"189","beta-catenin independent WNT signaling",0,"Pathway",8
"190","Beta-catenin phosphorylation cascade",0,"Pathway",8
"191","Beta1 integrin cell surface interactions",0,"Pathway",9
"192","Beta2 integrin cell surface interactions",0,"Pathway",9
"193","Beta3 integrin cell surface interactions",0,"Pathway",9
"194","Beta5 beta6 beta7 and beta8 integrin cell surface interactions",0,"Pathway",9
"195","BFAR",0,"Gene",9
"196","BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members",0,"Pathway",9
"197","Bile acid and bile salt metabolism",0,"Pathway",9
"198","Binding and Uptake of Ligands by Scavenger Receptors",0,"Pathway",9
"199","binding of TCF/LEF:CTNNB1 to target gene promoters",0,"Pathway",9
"200","Biological oxidations",0,"Pathway",9
"201","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0,"Pathway",9
"202","BIRC5",19,"Gene",95
"203","Bladder Cancer",0,"Pathway",9
"204","BMAL1:CLOCK,NPAS2 activates circadian gene expression",0,"Pathway",9
"205","BMI1",5,"Gene",84
"206","BMP receptor signaling",0,"Pathway",9
"207","Branched-chain amino acid catabolism",0,"Pathway",9
"208","BTK",25,"Gene",97
"209","Budding and maturation of HIV virion",0,"Pathway",9
"210","Bupropion",42,"Compound",99
"211","C-MYB transcription factor network",0,"Pathway",9
"212","C-MYC pathway",0,"Pathway",9
"213","C14orf1",0,"Gene",9
"214","C1QBP",3,"Gene",81
"215","C2CD2",0,"Gene",10
"216","C2CD5",2,"Gene",79
"217","Calcineurin-regulated NFAT-dependent transcription in lymphocytes",0,"Pathway",10
"218","Calcitonin-like ligand receptors",0,"Pathway",10
"219","Calcium Regulation in the Cardiac Cell",0,"Pathway",10
"220","Calcium signaling in the CD4+ TCR pathway",0,"Pathway",10
"221","Calnexin/calreticulin cycle",0,"Pathway",10
"222","CAMSAP1",0,"Gene",10
"223","Canonical NF-kappaB pathway",0,"Pathway",10
"224","Canonical Wnt signaling pathway",0,"Pathway",10
"225","CANT1",0,"Gene",10
"226","Cap-dependent Translation Initiation",0,"Pathway",10
"227","CAPN3",1,"Gene",78
"228","CAPN7",1,"Gene",78
"229","Carbohydrate metabolism",0,"Pathway",10
"230","Cardiac Hypertrophic Response",0,"Pathway",10
"231","Cardiac Progenitor Differentiation",0,"Pathway",10
"232","CASP2",18,"Gene",95
"233","Caspase Cascade in Apoptosis",0,"Pathway",10
"234","CAST",0,"Gene",10
"235","CCNA2",40,"Gene",98
"236","CCP110",7,"Gene",87
"237","CCT2",8,"Gene",89
"238","CCT3",8,"Gene",89
"239","CCT5",8,"Gene",89
"240","CD28 co-stimulation",0,"Pathway",10
"241","CD28 dependent PI3K/Akt signaling",0,"Pathway",10
"242","CD28 dependent Vav1 pathway",0,"Pathway",10
"243","CD2BP2",4,"Gene",82
"244","CD40/CD40L signaling",0,"Pathway",11
"245","CD44",18,"Gene",95
"246","CDC14B",2,"Gene",80
"247","CDC20",30,"Gene",98
"248","Cdc20:Phospho-APC/C mediated degradation of Cyclin A",0,"Pathway",11
"249","CDC25B",18,"Gene",95
"250","CDC42 signaling events",0,"Pathway",11
"251","CDC6 association with the ORC:origin complex",0,"Pathway",11
"252","CDH1",34,"Gene",98
"253","CDK-mediated phosphorylation and removal of Cdc6",0,"Pathway",11
"254","CDK7",48,"Gene",99
"255","CDT1 association with the CDC6:ORC:origin complex",0,"Pathway",11
"256","CEBPB",28,"Gene",97
"257","Cell-Cell communication",0,"Pathway",11
"258","Cell-cell junction organization",0,"Pathway",11
"259","Cell-extracellular matrix interactions",0,"Pathway",11
"260","Cell Cycle",0,"Pathway",11
"261","Cell Cycle",0,"Pathway",11
"262","Cell Cycle",0,"Pathway",11
"263","Cell Cycle",0,"Pathway",11
"264","Cell Cycle Checkpoints",0,"Pathway",11
"265","Cell Cycle, Mitotic",0,"Pathway",11
"266","Cell death signalling via NRAGE, NRIF and NADE",0,"Pathway",11
"267","Cell Differentiation - Index",0,"Pathway",11
"268","cell division",0,"BiologicalProcess",11
"269","cell division",0,"Pathway",11
"270","Cell junction organization",0,"Pathway",12
"271","Cell surface interactions at the vascular wall",0,"Pathway",12
"272","Cellular response to heat stress",0,"Pathway",12
"273","Cellular response to hypoxia",0,"Pathway",12
"274","Cellular responses to stress",0,"Pathway",12
"275","Cellular Senescence",0,"Pathway",12
"276","Centrosome maturation",0,"Pathway",12
"277","CEP192",8,"Gene",89
"278","CEP76",7,"Gene",87
"279","Ceramide signaling pathway",0,"Pathway",12
"280","CERK",8,"Gene",89
"281","Chaperonin-mediated protein folding",0,"Pathway",12
"282","Chemokine receptors bind chemokines",0,"Pathway",12
"283","CHL1 interactions",0,"Pathway",12
"284","CHMP1A",0,"Gene",12
"285","Cholesterol biosynthesis",0,"Pathway",12
"286","Cholesterol Biosynthesis",0,"Pathway",12
"287","Chondroitin sulfate/dermatan sulfate metabolism",0,"Pathway",12
"288","CHRFAM7A",0,"Gene",12
"289","CHRM1",15,"Gene",94
"290","CHRM2",14,"Gene",93
"291","CHRM3",18,"Gene",95
"292","CHRM4",12,"Gene",92
"293","CHRM5",13,"Gene",92
"294","CHRNA3",10,"Gene",91
"295","CHRNA4",10,"Gene",91
"296","CHRNA6",8,"Gene",89
"297","CHRNA7",6,"Gene",86
"298","CHRNB2",11,"Gene",91
"299","CHRNB4",10,"Gene",91
"300","Chromatin modifying enzymes",0,"Pathway",12
"301","Chromosome Maintenance",0,"Pathway",12
"302","Chylomicron-mediated lipid transport",0,"Pathway",12
"303","Circadian Clock",0,"Pathway",13
"304","Circadian rhythm pathway",0,"Pathway",13
"305","Circadian rythm related genes",0,"Pathway",13
"306","Citric acid cycle (TCA cycle)",0,"Pathway",13
"307","Class A/1 (Rhodopsin-like receptors)",0,"Pathway",13
"308","Class B/2 (Secretin family receptors)",0,"Pathway",13
"309","Class I MHC mediated antigen processing & presentation",0,"Pathway",13
"310","Class I PI3K signaling events",0,"Pathway",13
"311","Class I PI3K signaling events mediated by Akt",0,"Pathway",13
"312","Clathrin derived vesicle budding",0,"Pathway",13
"313","Clearance of dopamine",0,"Pathway",13
"314","Clearance of Nuclear Envelope Membranes from Chromatin",0,"Pathway",13
"315","Cleavage of Growing Transcript in the Termination Region",0,"Pathway",13
"316","Cleavage of the damaged purine",0,"Pathway",13
"317","Clonidine",32,"Compound",98
"318","CNOT2",5,"Gene",84
"319","Codeine and Morphine Metabolism",0,"Pathway",13
"320","COG7",0,"Gene",13
"321","COL11A1",8,"Gene",89
"322","COL9A3",14,"Gene",93
"323","COLGALT1",3,"Gene",81
"324","Collagen biosynthesis and modifying enzymes",0,"Pathway",13
"325","Collagen degradation",0,"Pathway",13
"326","Collagen formation",0,"Pathway",13
"327","Common Pathway",0,"Pathway",14
"328","Complement and Coagulation Cascades",0,"Pathway",14
"329","Complement cascade",0,"Pathway",14
"330","Composition of Lipid Particles",0,"Pathway",14
"331","Condensation of Prometaphase Chromosomes",0,"Pathway",14
"332","Condensation of Prophase Chromosomes",0,"Pathway",14
"333","Constitutive Androstane Receptor Pathway",0,"Pathway",14
"334","Constitutive PI3K/AKT Signaling in Cancer",0,"Pathway",14
"335","Constitutive Signaling by NOTCH1 HD Domain Mutants",0,"Pathway",14
"336","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0,"Pathway",14
"337","Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant",0,"Pathway",14
"338","Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase",0,"Pathway",14
"339","Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding",0,"Pathway",14
"340","Copper homeostasis",0,"Pathway",14
"341","COPS3",0,"Gene",14
"342","Coregulation of Androgen receptor activity",0,"Pathway",14
"343","Cori Cycle",0,"Pathway",14
"344","Corticotropin-releasing hormone",0,"Pathway",14
"345","Costimulation by the CD28 family",0,"Pathway",14
"346","COX4I1",7,"Gene",87
"347","COX7B",7,"Gene",87
"348","COX8A",8,"Gene",89
"349","CRK",62,"Gene",100
"350","CRMPs in Sema3A signaling",0,"Pathway",15
"351","Cross-presentation of soluble exogenous antigens (endosomes)",0,"Pathway",15
"352","Crosslinking of collagen fibrils",0,"Pathway",15
"353","CRYZ",0,"Gene",15
"354","CTLA4 inhibitory signaling",0,"Pathway",15
"355","CTSD",13,"Gene",92
"356","CTSL",15,"Gene",94
"357","CXCR3-mediated signaling events",0,"Pathway",15
"358","CXCR4-mediated signaling events",0,"Pathway",15
"359","Cyclin A/B1 associated events during G2/M transition",0,"Pathway",15
"360","Cyclin A:Cdk2-associated events at S phase entry",0,"Pathway",15
"361","Cyclin B2 mediated events",0,"Pathway",15
"362","Cyclin D associated events in G1",0,"Pathway",15
"363","Cyclin E associated events during G1/S transition",0,"Pathway",15
"364","CYCS",31,"Gene",98
"365","CYP1A1",24,"Gene",97
"366","CYP1A2",27,"Gene",97
"367","CYP2A6",14,"Gene",93
"368","CYP2B6",14,"Gene",93
"369","CYP2C19",16,"Gene",95
"370","CYP2C8",15,"Gene",94
"371","CYP2C9",16,"Gene",95
"372","CYP2D6",14,"Gene",93
"373","CYP2E1",15,"Gene",94
"374","CYP2E1 reactions",0,"Pathway",15
"375","CYP3A4",23,"Gene",96
"376","CYP3A5",11,"Gene",91
"377","CYP51A1",13,"Gene",92
"378","CYTH1",1,"Gene",78
"379","Cytisine",6,"Compound",86
"380","Cytochrome P450 - arranged by substrate type",0,"Pathway",15
"381","Cytokine Signaling in Immune system",0,"Pathway",15
"382","Cytokines and Inflammatory Response",0,"Pathway",15
"383","Cytoplasmic Ribosomal Proteins",0,"Pathway",15
"384","Cytosolic iron-sulfur cluster assembly",0,"Pathway",15
"385","Cytosolic sensors of pathogen-associated DNA",0,"Pathway",15
"386","DAD1",3,"Gene",81
"387","DAP12 interactions",0,"Pathway",16
"388","DAP12 signaling",0,"Pathway",16
"389","DBP",3,"Gene",81
"390","DCC mediated attractive signaling",0,"Pathway",16
"391","DCTPP1",0,"Gene",16
"392","DDIT4",3,"Gene",81
"393","DDX47",0,"Gene",16
"394","deactivation of the beta-catenin transactivating complex",0,"Pathway",16
"395","Deadenylation-dependent mRNA decay",0,"Pathway",16
"396","Deadenylation of mRNA",0,"Pathway",16
"397","DECR2",0,"Gene",16
"398","Defective AMN causes hereditary megaloblastic anemia 1",0,"Pathway",16
"399","Defective B3GAT3 causes JDSSDHD",0,"Pathway",16
"400","degradation of AXIN",0,"Pathway",16
"401","degradation of DVL",0,"Pathway",16
"402","Degradation of GLI1 by the proteasome",0,"Pathway",16
"403","Degradation of GLI2 by the proteasome",0,"Pathway",16
"404","Degradation of the extracellular matrix",0,"Pathway",16
"405","DENND3",0,"Gene",16
"406","Deposition of new CENPA-containing nucleosomes at the centromere",0,"Pathway",16
"407","Detoxification of Reactive Oxygen Species",0,"Pathway",16
"408","Developmental Biology",0,"Pathway",17
"409","DEx/H-box helicases activate type I IFN and inflammatory cytokines production",0,"Pathway",17
"410","DHCR7",7,"Gene",88
"411","DHX29",0,"Gene",17
"412","Diclofenac Metabolic Pathway",0,"Pathway",17
"413","Differentiation of white and brown adipocyte   ",0,"Pathway",17
"414","Differentiation Pathway",0,"Pathway",17
"415","DIRAS3",0,"Gene",17
"416","Direct p53 effectors",0,"Pathway",17
"417","disassembly of the destruction complex and recruitment of AXIN to the membrane",0,"Pathway",17
"418","Disease",0,"Pathway",17
"419","Diseases associated with visual transduction",0,"Pathway",17
"420","Displacement of DNA glycosylase by APE1",0,"Pathway",17
"421","Diurnally Regulated Genes with Circadian Orthologs",0,"Pathway",17
"422","DLD",13,"Gene",92
"423","DNA-PK pathway in nonhomologous end joining",0,"Pathway",17
"424","DNA Damage Response",0,"Pathway",17
"425","DNA Damage Response (only ATM dependent)",0,"Pathway",17
"426","DNA Damage/Telomere Stress Induced Senescence",0,"Pathway",17
"427","DNA methylation",0,"Pathway",17
"428","DNA Repair",0,"Pathway",17
"429","DNA Replication",0,"Pathway",18
"430","DNA Replication",0,"Pathway",18
"431","DNA Replication",0,"Pathway",18
"432","DNA Replication",0,"Pathway",18
"433","DNA Replication Pre-Initiation",0,"Pathway",18
"434","DNA strand elongation",0,"Pathway",18
"435","DNAJA3",1,"Gene",78
"436","DNAJB6",0,"Gene",18
"437","DNM1L",3,"Gene",81
"438","DNTTIP2",0,"Gene",18
"439","DOCK9",3,"Gene",81
"440","Dopamine metabolism",0,"Pathway",18
"441","Dopamine Neurotransmitter Release Cycle",0,"Pathway",18
"442","Dopamine receptors",0,"Pathway",18
"443","Dopaminergic Neurogenesis",0,"Pathway",18
"444","Double-Strand Break Repair",0,"Pathway",18
"445","Downregulation of ERBB2:ERBB3 signaling",0,"Pathway",18
"446","Downregulation of ERBB4 signaling",0,"Pathway",18
"447","Downregulation of SMAD2/3:SMAD4 transcriptional activity",0,"Pathway",18
"448","Downregulation of TGF-beta receptor signaling",0,"Pathway",18
"449","Downstream signal transduction",0,"Pathway",18
"450","Downstream signaling events of B Cell Receptor (BCR)",0,"Pathway",18
"451","Downstream signaling in naïve CD8+ T cells",0,"Pathway",19
"452","Downstream signaling of activated FGFR",0,"Pathway",19
"453","Downstream TCR signaling",0,"Pathway",19
"454","DPH2",0,"Gene",19
"455","DPYSL2",7,"Gene",88
"456","DRAP1",4,"Gene",82
"457","DRD2",13,"Gene",93
"458","Drug Induction of Bile Acid Pathway",0,"Pathway",19
"459","DSCAM interactions",0,"Pathway",19
"460","DSG2",5,"Gene",85
"461","Dual hijack model of Vif in HIV infection",0,"Pathway",19
"462","Dual incision reaction in GG-NER",0,"Pathway",19
"463","Dual incision reaction in TC-NER",0,"Pathway",19
"464","DYNC1LI2",3,"Gene",81
"465","DYRK1A",6,"Gene",86
"466","E-cadherin signaling events",0,"Pathway",19
"467","E-cadherin signaling in keratinocytes",0,"Pathway",19
"468","E-cadherin signaling in the nascent adherens junction",0,"Pathway",19
"469","E2F mediated regulation of DNA replication",0,"Pathway",19
"470","E2F transcription factor network",0,"Pathway",19
"471","E2F2",21,"Gene",96
"472","Early Phase of HIV Life Cycle",0,"Pathway",19
"473","EBP",3,"Gene",82
"474","EBV LMP1 signaling",0,"Pathway",19
"475","ECH1",1,"Gene",78
"476","ECM proteoglycans",0,"Pathway",19
"477","Ectoderm Differentiation",0,"Pathway",19
"478","EDEM1",9,"Gene",90
"479","EEF1A2",5,"Gene",85
"480","Effects of Botulinum toxin",0,"Pathway",19
"481","Effects of PIP2 hydrolysis",0,"Pathway",20
"482","EGF/EGFR Signaling Pathway",0,"Pathway",20
"483","EGFR-dependent Endothelin signaling events",0,"Pathway",20
"484","EGFR downregulation",0,"Pathway",20
"485","EGR1",26,"Gene",97
"486","EGR2",7,"Gene",88
"487","Eicosanoid Synthesis",0,"Pathway",20
"488","EIF3I",12,"Gene",92
"489","EIF4ENIF1",0,"Gene",20
"490","EIF6",1,"Gene",78
"491","ELAC2",0,"Gene",20
"492","Elastic fibre formation",0,"Pathway",20
"493","Electron Transport Chain",0,"Pathway",20
"494","Elongation arrest and recovery",0,"Pathway",20
"495","ELOVL6",8,"Gene",89
"496","Endochondral Ossification",0,"Pathway",20
"497","Endoderm Differentiation",0,"Pathway",20
"498","Endogenous sterols",0,"Pathway",20
"499","Endogenous TLR signaling",0,"Pathway",20
"500","Endosomal Sorting Complex Required For Transport (ESCRT)",0,"Pathway",20
"501","Endosomal/Vacuolar pathway",0,"Pathway",20
"502","Endothelin Pathways",0,"Pathway",20
"503","Endothelins",0,"Pathway",20
"504","Energy dependent regulation of mTOR by LKB1-AMPK",0,"Pathway",20
"505","ENOPH1",5,"Gene",85
"506","eNOS activation",0,"Pathway",21
"507","EPH-ephrin mediated repulsion of cells",0,"Pathway",21
"508","EPH-Ephrin signaling",0,"Pathway",21
"509","EPHA-mediated growth cone collapse",0,"Pathway",21
"510","EPHA forward signaling",0,"Pathway",21
"511","EPHA2 forward signaling",0,"Pathway",21
"512","EPHA3",8,"Gene",90
"513","EPHB-mediated forward signaling",0,"Pathway",21
"514","EPHB forward signaling",0,"Pathway",21
"515","Ephrin A reverse signaling",0,"Pathway",21
"516","Ephrin B reverse signaling",0,"Pathway",21
"517","Ephrin signaling",0,"Pathway",21
"518","EphrinA-EPHA pathway",0,"Pathway",21
"519","Epigenetic regulation of gene expression",0,"Pathway",21
"520","EPO Receptor Signaling",0,"Pathway",21
"521","EPO signaling pathway",0,"Pathway",21
"522","ER-Phagosome pathway",0,"Pathway",21
"523","ER Quality Control Compartment (ERQC)",0,"Pathway",21
"524","ERAP2",4,"Gene",82
"525","ErbB receptor signaling network",0,"Pathway",21
"526","ErbB Signaling Pathway",0,"Pathway",21
"527","ErbB1 downstream signaling",0,"Pathway",22
"528","ErbB2/ErbB3 signaling events",0,"Pathway",22
"529","ERBB3",37,"Gene",98
"530","ErbB4 signaling events",0,"Pathway",22
"531","ERH",0,"Gene",22
"532","ERI3",0,"Gene",22
"533","Estrogen metabolism",0,"Pathway",22
"534","Estrogen Receptor Pathway",0,"Pathway",22
"535","Estrogen signaling pathway",0,"Pathway",22
"536","ETFB",4,"Gene",83
"537","Eukaryotic Transcription Initiation",0,"Pathway",22
"538","Eukaryotic Translation Elongation",0,"Pathway",22
"539","Eukaryotic Translation Termination",0,"Pathway",22
"540","EVC",0,"Gene",22
"541","EVL",7,"Gene",88
"542","Evolocumab Mechanism",0,"Pathway",22
"543","Export of Viral Ribonucleoproteins from Nucleus",0,"Pathway",22
"544","Extension of Telomeres",0,"Pathway",22
"545","Extracellular matrix organization",0,"Pathway",22
"546","EYA2",0,"Gene",22
"547","EZH2",13,"Gene",93
"548","Facilitative Na+-independent glucose transporters",0,"Pathway",22
"549","Factors involved in megakaryocyte development and platelet production",0,"Pathway",22
"550","FADS2",4,"Gene",83
"551","FAM188A",0,"Gene",23
"552","FAM50A",0,"Gene",23
"553","FAM69A",0,"Gene",23
"554","FAM96B",2,"Gene",80
"555","Fanconi anemia pathway",0,"Pathway",23
"556","Fanconi Anemia pathway",0,"Pathway",23
"557","Farnesoid X Receptor  Pathway",0,"Pathway",23
"558","FAS (CD95) signaling pathway",0,"Pathway",23
"559","FAS pathway and Stress induction of HSP regulation",0,"Pathway",23
"560","Fatty Acid Beta Oxidation",0,"Pathway",23
"561","Fatty Acid Biosynthesis",0,"Pathway",23
"562","Fatty Acid Omega Oxidation",0,"Pathway",23
"563","Fatty acid, triacylglycerol, and ketone body metabolism",0,"Pathway",23
"564","Fatty acids",0,"Pathway",23
"565","Fatty Acyl-CoA Biosynthesis",0,"Pathway",23
"566","FBL",0,"Gene",23
"567","FBXL5",4,"Gene",83
"568","FBXW7 Mutants and NOTCH1 in Cancer",0,"Pathway",23
"569","Fc-epsilon receptor I signaling in mast cells",0,"Pathway",23
"570","Fc epsilon receptor (FCERI) signaling",0,"Pathway",23
"571","FCERI mediated Ca+2 mobilization",0,"Pathway",23
"572","FCERI mediated MAPK activation",0,"Pathway",24
"573","FCERI mediated NF-kB activation",0,"Pathway",24
"574","Fcgamma receptor (FCGR) dependent phagocytosis",0,"Pathway",24
"575","FCGR activation",0,"Pathway",24
"576","FDFT1",11,"Gene",91
"577","FDPS",7,"Gene",88
"578","Felbamate Metabolism",0,"Pathway",24
"579","FGF signaling pathway",0,"Pathway",24
"580","FGF1",54,"Gene",100
"581","FGFR ligand binding and activation",0,"Pathway",24
"582","FGFR1 ligand binding and activation",0,"Pathway",24
"583","FGFR1b ligand binding and activation",0,"Pathway",24
"584","FGFR1c ligand binding and activation",0,"Pathway",24
"585","FGFR2b ligand binding and activation",0,"Pathway",24
"586","FGFR2c ligand binding and activation",0,"Pathway",24
"587","FGFR3 ligand binding and activation",0,"Pathway",24
"588","FGFR3b ligand binding and activation",0,"Pathway",24
"589","FGFR4 ligand binding and activation",0,"Pathway",24
"590","FIS1",0,"Gene",24
"591","FKBP4",7,"Gene",88
"592","Fluoropyrimidine Activity",0,"Pathway",24
"593","Focal Adhesion",0,"Pathway",24
"594","Folate-Alcohol and Cancer Pathway",0,"Pathway",24
"595","Folate Metabolism",0,"Pathway",25
"596","Folding of actin by CCT/TriC",0,"Pathway",25
"597","Formation of a pool of free 40S subunits",0,"Pathway",25
"598","Formation of annular gap junctions",0,"Pathway",25
"599","Formation of apoptosome",0,"Pathway",25
"600","Formation of Fibrin Clot (Clotting Cascade)",0,"Pathway",25
"601","Formation of HIV-1 elongation complex containing HIV-1 Tat",0,"Pathway",25
"602","Formation of HIV elongation complex in the absence of HIV Tat",0,"Pathway",25
"603","Formation of Senescence-Associated Heterochromatin Foci (SAHF)",0,"Pathway",25
"604","formation of the beta-catenin:TCF transactivating complex",0,"Pathway",25
"605","Formation of the Early Elongation Complex",0,"Pathway",25
"606","Formation of the ternary complex, and subsequently, the 43S complex",0,"Pathway",25
"607","Formation of tubulin folding intermediates by CCT/TriC",0,"Pathway",25
"608","Formyl peptide receptors bind formyl peptides and many other ligands",0,"Pathway",25
"609","FOXA1 transcription factor network",0,"Pathway",25
"610","FOXA2 and FOXA3 transcription factor networks",0,"Pathway",25
"611","FOXM1 transcription factor network",0,"Pathway",25
"612","FoxO family signaling",0,"Pathway",25
"613","FOXO3",51,"Gene",99
"614","FOXO4",35,"Gene",98
"615","FPGS",5,"Gene",85
"616","FRS2-mediated cascade",0,"Pathway",25
"617","FSH signaling pathway",0,"Pathway",26
"618","FTO Obesity Variant Mechanism",0,"Pathway",26
"619","FYN",111,"Gene",100
"620","FZD7",13,"Gene",93
"621","G-protein activation",0,"Pathway",26
"622","G-protein beta:gamma signalling",0,"Pathway",26
"623","G-protein mediated events",0,"Pathway",26
"624","G alpha (12/13) signalling events",0,"Pathway",26
"625","G alpha (i) signalling events",0,"Pathway",26
"626","G alpha (q) signalling events",0,"Pathway",26
"627","G alpha (s) signalling events",0,"Pathway",26
"628","G alpha (z) signalling events",0,"Pathway",26
"629","G beta:gamma signalling through PI3Kgamma",0,"Pathway",26
"630","G Protein Signaling Pathways",0,"Pathway",26
"631","G0 and Early G1",0,"Pathway",26
"632","G1 to S cell cycle control",0,"Pathway",26
"633","G1/S-Specific Transcription",0,"Pathway",26
"634","G1/S DNA Damage Checkpoints",0,"Pathway",26
"635","G1/S Transition",0,"Pathway",26
"636","G13 Signaling Pathway",0,"Pathway",26
"637","G2 Phase",0,"Pathway",26
"638","G2/M Checkpoints",0,"Pathway",27
"639","G2/M Transition",0,"Pathway",27
"640","G6PD",8,"Gene",90
"641","GAB1 signalosome",0,"Pathway",27
"642","GABA receptor activation",0,"Pathway",27
"643","GABA synthesis, release, reuptake and degradation",0,"Pathway",27
"644","Gamma-carboxylation of protein precursors",0,"Pathway",27
"645","Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",0,"Pathway",27
"646","Gap-filling DNA repair synthesis and ligation in GG-NER",0,"Pathway",27
"647","Gap junction assembly",0,"Pathway",27
"648","Gap junction degradation",0,"Pathway",27
"649","Gap junction trafficking",0,"Pathway",27
"650","Gap junction trafficking and regulation",0,"Pathway",27
"651","GAS7",0,"Gene",27
"652","Gastric Cancer Network 1",0,"Pathway",27
"653","Gastric Cancer Network 2",0,"Pathway",27
"654","Gastrin-CREB signalling pathway via PKC and MAPK",0,"Pathway",27
"655","GATA3",14,"Gene",94
"656","Gene Expression",0,"Pathway",27
"657","Gene regulatory network modelling somitogenesis ",0,"Pathway",27
"658","Generation of second messenger molecules",0,"Pathway",27
"659","Generic Transcription Pathway",0,"Pathway",28
"660","GHR",9,"Gene",90
"661","GJA1",21,"Gene",96
"662","GK",8,"Gene",90
"663","GLI3 is processed to GLI3R by the proteasome",0,"Pathway",28
"664","Glial Cell Differentiation",0,"Pathway",28
"665","Global Genomic NER (GG-NER)",0,"Pathway",28
"666","Globo Sphingolipid Metabolism",0,"Pathway",28
"667","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion",0,"Pathway",28
"668","Glucagon-type ligand receptors",0,"Pathway",28
"669","Glucagon signaling in metabolic regulation",0,"Pathway",28
"670","Glucocorticoid receptor regulatory network",0,"Pathway",28
"671","Gluconeogenesis",0,"Pathway",28
"672","Glucose metabolism",0,"Pathway",28
"673","Glucose transport",0,"Pathway",28
"674","Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity",0,"Pathway",28
"675","Glutamate Neurotransmitter Release Cycle",0,"Pathway",28
"676","Glutathione conjugation",0,"Pathway",28
"677","Glutathione metabolism",0,"Pathway",28
"678","Glycerophospholipid biosynthesis",0,"Pathway",28
"679","Glycerophospholipid Biosynthetic Pathway",0,"Pathway",28
"680","Glycogen Metabolism",0,"Pathway",28
"681","Glycogen synthesis",0,"Pathway",29
"682","Glycolysis",0,"Pathway",29
"683","Glycolysis and Gluconeogenesis",0,"Pathway",29
"684","Glycosphingolipid metabolism",0,"Pathway",29
"685","Glypican 1 network",0,"Pathway",29
"686","GMCSF-mediated signaling events",0,"Pathway",29
"687","GMNN",11,"Gene",91
"688","GNAI2",46,"Gene",99
"689","GNAS",31,"Gene",98
"690","Golgi Associated Vesicle Biogenesis",0,"Pathway",29
"691","GPATCH8",0,"Gene",29
"692","GPCR downstream signaling",0,"Pathway",29
"693","GPCR ligand binding",0,"Pathway",29
"694","GPCRs, Class A Rhodopsin-like",0,"Pathway",29
"695","GPCRs, Class B Secretin-like",0,"Pathway",29
"696","GPCRs, Other",0,"Pathway",29
"697","GPER1",9,"Gene",90
"698","GPVI-mediated activation cascade",0,"Pathway",29
"699","GRAMD4",1,"Gene",78
"700","GRB2:SOS provides linkage to MAPK signaling for Integrins",0,"Pathway",29
"701","GRB7",15,"Gene",94
"702","GRB7 events in ERBB2 signaling",0,"Pathway",29
"703","Growth hormone receptor signaling",0,"Pathway",29
"704","GRWD1",0,"Gene",29
"705","GSTT2",8,"Gene",90
"706","GTP hydrolysis and joining of the 60S ribosomal subunit",0,"Pathway",29
"707","GTPBP1",0,"Gene",30
"708","GTPBP8",0,"Gene",30
"709","Hair Follicle Development: Induction (Part 1 of 3)",0,"Pathway",30
"710","HAT1",2,"Gene",80
"711","HATs acetylate histones",0,"Pathway",30
"712","HAUS7",0,"Gene",30
"713","HDAC2",35,"Gene",98
"714","HDAC5",14,"Gene",94
"715","HDAC6",14,"Gene",94
"716","HDACs deacetylate histones",0,"Pathway",30
"717","HDL-mediated lipid transport",0,"Pathway",30
"718","HDMs demethylate histones",0,"Pathway",30
"719","Heart Development",0,"Pathway",30
"720","Hedgehog 'off' state",0,"Pathway",30
"721","Hedgehog ligand biogenesis",0,"Pathway",30
"722","Hedgehog signaling events mediated by Gli proteins",0,"Pathway",30
"723","Hematopoietic Stem Cell Differentiation",0,"Pathway",30
"724","Heme degradation",0,"Pathway",30
"725","Hemostasis",0,"Pathway",30
"726","Heparan sulfate/heparin (HS-GAG) metabolism",0,"Pathway",30
"727","HERC1",0,"Gene",30
"728","HERC5",7,"Gene",88
"729","Hexose uptake",0,"Pathway",30
"730","Hh ligand biogenesis disease",0,"Pathway",30
"731","HIF-1-alpha transcription factor network",0,"Pathway",31
"732","HIF-2-alpha transcription factor network",0,"Pathway",31
"733","Highly calcium permeable nicotinic acetylcholine receptors",0,"Pathway",31
"734","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors",0,"Pathway",31
"735","Highly sodium permeable acetylcholine nicotinic receptors",0,"Pathway",31
"736","HIST1H4C",48,"Gene",99
"737","Histamine receptors",0,"Pathway",31
"738","Histone Modifications",0,"Pathway",31
"739","HIV-1 Nef: Negative effector of Fas and TNF-alpha",0,"Pathway",31
"740","HIV Infection",0,"Pathway",31
"741","HIV Life Cycle",0,"Pathway",31
"742","HIV Transcription Initiation",0,"Pathway",31
"743","HLA-DMA",5,"Gene",85
"744","HLA-DRA",19,"Gene",96
"745","HMGA2",5,"Gene",85
"746","HMGCR",15,"Gene",94
"747","HMGCS1",13,"Gene",93
"748","HMOX2",5,"Gene",85
"749","Homologous DNA pairing and strand exchange",0,"Pathway",31
"750","Homologous recombination",0,"Pathway",31
"751","Homologous Recombination Repair",0,"Pathway",31
"752","HOOK2",0,"Gene",31
"753","Host Interactions of HIV factors",0,"Pathway",31
"754","Host Interactions with Influenza Factors",0,"Pathway",31
"755","HRH1",12,"Gene",92
"756","HS-GAG biosynthesis",0,"Pathway",31
"757","HS-GAG degradation",0,"Pathway",31
"758","HSD17B7",4,"Gene",83
"759","HSF1-dependent transactivation",0,"Pathway",32
"760","HSF1 activation",0,"Pathway",32
"761","HSP90AA1",63,"Gene",100
"762","HSPA8",29,"Gene",97
"763","HSPB1",14,"Gene",94
"764","HSPD1",6,"Gene",86
"765","HSPE1",0,"Gene",32
"766","HTATSF1",0,"Gene",32
"767","HTR1A",11,"Gene",92
"768","HTR2A",15,"Gene",94
"769","HTR2C",12,"Gene",92
"770","HTR6",11,"Gene",92
"771","Hyaluronan biosynthesis and export",0,"Pathway",32
"772","Hyaluronan metabolism",0,"Pathway",32
"773","Hyaluronan uptake and degradation",0,"Pathway",32
"774","Hypertrophy Model",0,"Pathway",32
"775","Hypothetical Network for Drug Addiction",0,"Pathway",32
"776","Hypoxic and oxygen homeostasis regulation of HIF-1-alpha",0,"Pathway",32
"777","IARS2",3,"Gene",82
"778","ICAM1",20,"Gene",96
"779","ICAM3",6,"Gene",86
"780","ID signaling pathway",0,"Pathway",32
"781","IDI1",9,"Gene",90
"782","IFN-gamma pathway",0,"Pathway",32
"783","IFRD2",0,"Gene",32
"784","IFT27",0,"Gene",32
"785","IGF1 pathway",0,"Pathway",32
"786","IGF1R signaling cascade",0,"Pathway",32
"787","IGF2BP2",2,"Gene",80
"788","IKK complex recruitment mediated by RIP1",0,"Pathway",32
"789","IKZF1",2,"Gene",80
"790","IL-1 signaling pathway",0,"Pathway",32
"791","IL-2 Signaling Pathway",0,"Pathway",32
"792","IL-3 Signaling Pathway",0,"Pathway",33
"793","IL-4 Signaling Pathway",0,"Pathway",33
"794","IL-5 Signaling Pathway",0,"Pathway",33
"795","IL-6 signaling pathway",0,"Pathway",33
"796","IL-7 Signaling Pathway",0,"Pathway",33
"797","IL-9 Signaling Pathway",0,"Pathway",33
"798","IL1-mediated signaling events",0,"Pathway",33
"799","IL1 and megakaryotyces in obesity",0,"Pathway",33
"800","IL12-mediated signaling events",0,"Pathway",33
"801","IL12 signaling mediated by STAT4",0,"Pathway",33
"802","IL17 signaling pathway",0,"Pathway",33
"803","IL2-mediated signaling events",0,"Pathway",33
"804","IL2 signaling events mediated by PI3K",0,"Pathway",33
"805","IL2 signaling events mediated by STAT5",0,"Pathway",33
"806","IL23-mediated signaling events",0,"Pathway",33
"807","IL27-mediated signaling events",0,"Pathway",33
"808","IL3-mediated signaling events",0,"Pathway",33
"809","IL4-mediated signaling events",0,"Pathway",33
"810","IL5-mediated signaling events",0,"Pathway",33
"811","IL6-mediated signaling events",0,"Pathway",34
"812","IL8- and CXCR1-mediated signaling events",0,"Pathway",34
"813","IL8- and CXCR2-mediated signaling events",0,"Pathway",34
"814","Imatinib Resistance in Chronic Myeloid Leukemia",0,"Pathway",34
"815","Immune System",0,"Pathway",34
"816","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell",0,"Pathway",34
"817","Import of palmitoyl-CoA into the mitochondrial matrix",0,"Pathway",34
"818","Inactivation of APC/C via direct inhibition of the APC/C complex",0,"Pathway",34
"819","Inactivation, recovery and regulation of the phototransduction cascade",0,"Pathway",34
"820","Inflammasomes",0,"Pathway",34
"821","Inflammatory Response Pathway",0,"Pathway",34
"822","Influenza Infection",0,"Pathway",34
"823","Influenza Life Cycle",0,"Pathway",34
"824","Influenza Viral RNA Transcription and Replication",0,"Pathway",34
"825","Influenza Virus Induced Apoptosis",0,"Pathway",34
"826","ING1",1,"Gene",78
"827","Initiation of Nuclear Envelope Reformation",0,"Pathway",34
"828","Initiation of transcription and translation elongation at the HIV-1 LTR",0,"Pathway",34
"829","Innate Immune System",0,"Pathway",34
"830","Inositol phosphate metabolism",0,"Pathway",34
"831","INPP4B",8,"Gene",90
"832","INSIG1",4,"Gene",83
"833","Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA",0,"Pathway",35
"834","Insulin effects increased synthesis of Xylulose-5-Phosphate",0,"Pathway",35
"835","Insulin Pathway",0,"Pathway",35
"836","Insulin receptor recycling",0,"Pathway",35
"837","Insulin receptor signalling cascade",0,"Pathway",35
"838","Insulin Signaling",0,"Pathway",35
"839","Integrated Breast Cancer Pathway",0,"Pathway",35
"840","Integrated Cancer Pathway",0,"Pathway",35
"841","Integrated Pancreatic Cancer Pathway",0,"Pathway",35
"842","Integration of energy metabolism",0,"Pathway",35
"843","Integration of provirus",0,"Pathway",35
"844","Integrin-linked kinase signaling",0,"Pathway",35
"845","Integrin-mediated Cell Adhesion",0,"Pathway",35
"846","Integrin alphaIIb beta3 signaling",0,"Pathway",35
"847","Integrin cell surface interactions",0,"Pathway",35
"848","Integrin family cell surface interactions",0,"Pathway",35
"849","Integrins in angiogenesis",0,"Pathway",35
"850","Interaction between L1 and Ankyrins",0,"Pathway",35
"851","Interactions of Rev with host cellular proteins",0,"Pathway",35
"852","Interactions of Vpr with host cellular proteins",0,"Pathway",36
"853","Interactome of polycomb repressive complex 2 (PRC2) ",0,"Pathway",36
"854","Interferon alpha/beta signaling",0,"Pathway",36
"855","Interferon gamma signaling",0,"Pathway",36
"856","Interferon Signaling",0,"Pathway",36
"857","Interferon type I signaling pathways",0,"Pathway",36
"858","Interleukin-1 processing",0,"Pathway",36
"859","Interleukin-1 signaling",0,"Pathway",36
"860","Interleukin-11 Signaling Pathway",0,"Pathway",36
"861","Interleukin-2 signaling",0,"Pathway",36
"862","Interleukin-3, 5 and GM-CSF signaling",0,"Pathway",36
"863","Interleukin-7 signaling",0,"Pathway",36
"864","Interleukin receptor SHC signaling",0,"Pathway",36
"865","Internalization of ErbB1",0,"Pathway",36
"866","Intrinsic Pathway",0,"Pathway",36
"867","Intrinsic Pathway for Apoptosis",0,"Pathway",36
"868","Ion channel transport",0,"Pathway",36
"869","Ion transport by P-type ATPases",0,"Pathway",36
"870","IRAK1",39,"Gene",98
"871","IRAK1 recruits IKK complex",0,"Pathway",36
"872","IRAK2 mediated activation of TAK1 complex",0,"Pathway",37
"873","IRE1alpha activates chaperones",0,"Pathway",37
"874","IRF3-mediated induction of type I IFN",0,"Pathway",37
"875","IRF5",10,"Gene",91
"876","Irinotecan Pathway",0,"Pathway",37
"877","Iron uptake and transport",0,"Pathway",37
"878","IRS-mediated signalling",0,"Pathway",37
"879","IRS-related events",0,"Pathway",37
"880","IRS-related events triggered by IGF1R",0,"Pathway",37
"881","ISOC2",0,"Gene",37
"882","ITGB1BP1",0,"Gene",37
"883","ITGB3",48,"Gene",99
"884","JADE2",2,"Gene",80
"885","JMJD6",0,"Gene",37
"886","JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1",0,"Pathway",37
"887","JNK signaling in the CD4+ TCR pathway",0,"Pathway",37
"888","KANK1",0,"Gene",37
"889","KAT6B",2,"Gene",80
"890","KDM5D",2,"Gene",80
"891","KIAA1109",0,"Gene",37
"892","KIF2C",16,"Gene",95
"893","Kinesins",0,"Pathway",37
"894","KIT",34,"Gene",98
"895","Kit receptor signaling pathway",0,"Pathway",37
"896","KLHL21",4,"Gene",83
"897","KPNA2",7,"Gene",88
"898","KRT34",0,"Gene",37
"899","KRT81",0,"Gene",37
"900","L1CAM interactions",0,"Pathway",38
"901","Lagging Strand Synthesis",0,"Pathway",38
"902","LAMA3",20,"Gene",96
"903","LAMA5",13,"Gene",93
"904","Laminin interactions",0,"Pathway",38
"905","LAMTOR2",0,"Gene",38
"906","Late Phase of HIV Life Cycle",0,"Pathway",38
"907","Latent infection of Homo sapiens with Mycobacterium tuberculosis",0,"Pathway",38
"908","LCMT1",0,"Gene",38
"909","LCP2",18,"Gene",95
"910","LDHB",7,"Gene",88
"911","LDL endocytosis",0,"Pathway",38
"912","LDLR",22,"Gene",96
"913","Leading Strand Synthesis",0,"Pathway",38
"914","Leptin signaling pathway",0,"Pathway",38
"915","LGALS4",0,"Gene",38
"916","Lidocaine metabolism",0,"Pathway",38
"917","LIG1",32,"Gene",98
"918","Linoleic acid (LA) metabolism",0,"Pathway",38
"919","LIPA",1,"Gene",78
"920","Lipid and lipoprotein metabolism",0,"Pathway",38
"921","Lipoprotein metabolism",0,"Pathway",38
"922","LIPT1",0,"Gene",38
"923","Lissencephaly gene (LIS1) in neuronal migration and development",0,"Pathway",38
"924","Liver X Receptor Pathway",0,"Pathway",38
"925","LKB1 signaling events",0,"Pathway",38
"926","Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling",0,"Pathway",39
"927","Loss of Function of SMAD2/3 in Cancer",0,"Pathway",39
"928","Loss of Nlp from mitotic centrosomes",0,"Pathway",39
"929","LOXL1",5,"Gene",85
"930","LPA receptor mediated events",0,"Pathway",39
"931","LPL",20,"Gene",96
"932","LPP",1,"Gene",79
"933","LRRC41",4,"Gene",83
"934","LSS",7,"Gene",88
"935","LTN1",0,"Gene",39
"936","LUC7L",0,"Gene",39
"937","LY75",0,"Gene",39
"938","Lysine catabolism",0,"Pathway",39
"939","Lysosome Vesicle Biogenesis",0,"Pathway",39
"940","LYST",0,"Gene",39
"941","M Phase",0,"Pathway",39
"942","MAL",0,"Gene",39
"943","MALT1",16,"Gene",95
"944","MAMLD1",13,"Gene",93
"945","MAP kinase activation in TLR cascade",0,"Pathway",39
"946","MAPK Signaling Pathway",0,"Pathway",39
"947","MAPKAPK5",6,"Gene",86
"948","Matrix Metalloproteinases",0,"Pathway",39
"949","MBTPS1",7,"Gene",88
"950","MCM3AP",0,"Gene",39
"951","MCM7",25,"Gene",97
"952","MCTS1",0,"Gene",39
"953","ME2",0,"Gene",39
"954","Mecp2 and Associated Rett Syndrome",0,"Pathway",39
"955","Meiosis",0,"Pathway",40
"956","Meiotic recombination",0,"Pathway",40
"957","Meiotic synapsis",0,"Pathway",40
"958","Melatonin metabolism and effects",0,"Pathway",40
"959","Membrane binding and targetting of GAG proteins",0,"Pathway",40
"960","Membrane Trafficking",0,"Pathway",40
"961","Mesodermal Commitment Pathway",0,"Pathway",40
"962","MEST",0,"Gene",40
"963","Metabolism",0,"Pathway",40
"964","Metabolism of Angiotensinogen to Angiotensins",0,"Pathway",40
"965","Metabolism of folate and pterines",0,"Pathway",40
"966","Metabolism of lipids and lipoproteins",0,"Pathway",40
"967","Metabolism of mRNA",0,"Pathway",40
"968","Metabolism of nitric oxide",0,"Pathway",40
"969","Metabolism of polyamines",0,"Pathway",40
"970","Metabolism of proteins",0,"Pathway",40
"971","Metabolism of RNA",0,"Pathway",40
"972","Metapathway biotransformation",0,"Pathway",40
"973","Metastatic brain tumor",0,"Pathway",40
"974","Methionine salvage pathway",0,"Pathway",41
"975","Methylation",0,"Pathway",41
"976","METTL17",0,"Gene",41
"977","METTL4",0,"Gene",41
"978","MFAP3L",0,"Gene",41
"979","MFAP5-mediated ovarian cancer cell motility and invasiveness",0,"Pathway",41
"980","MGA",0,"Gene",41
"981","MHC class II antigen presentation",0,"Pathway",41
"982","MICALL1",0,"Gene",41
"983","MicroRNA (miRNA) biogenesis",0,"Pathway",41
"984","MicroRNAs in cardiomyocyte hypertrophy",0,"Pathway",41
"985","MIF",2,"Gene",80
"986","miRNA Biogenesis",0,"Pathway",41
"987","miRNA Regulation of DNA Damage Response",0,"Pathway",41
"988","miRNAs involved in DNA damage response",0,"Pathway",41
"989","miRs in Muscle Cell Differentiation",0,"Pathway",41
"990","Miscellaneous substrates",0,"Pathway",41
"991","Mismatch repair",0,"Pathway",41
"992","Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)",0,"Pathway",41
"993","Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)",0,"Pathway",41
"994","Mitochondrial biogenesis",0,"Pathway",42
"995","Mitochondrial Gene Expression",0,"Pathway",42
"996","Mitochondrial protein import",0,"Pathway",42
"997","Mitochondrial translation",0,"Pathway",42
"998","Mitochondrial translation elongation",0,"Pathway",42
"999","Mitochondrial translation initiation",0,"Pathway",42
"1000","Mitochondrial translation termination",0,"Pathway",42
"1001","Mitochondrial tRNA aminoacylation",0,"Pathway",42
"1002","Mitotic Anaphase",0,"Pathway",42
"1003","Mitotic G1-G1/S phases",0,"Pathway",42
"1004","Mitotic G2-G2/M phases",0,"Pathway",42
"1005","Mitotic M-M/G1 phases",0,"Pathway",42
"1006","Mitotic Metaphase and Anaphase",0,"Pathway",42
"1007","Mitotic Prometaphase",0,"Pathway",42
"1008","Mitotic Prophase",0,"Pathway",42
"1009","Mitotic Spindle Checkpoint",0,"Pathway",42
"1010","MLEC",4,"Gene",83
"1011","MMR",0,"Pathway",42
"1012","Molecules associated with elastic fibres",0,"Pathway",42
"1013","MON2",0,"Gene",42
"1014","Monoamine GPCRs",0,"Pathway",43
"1015","Monoamine Transport",0,"Pathway",43
"1016","MPC2",5,"Gene",85
"1017","MPG",9,"Gene",90
"1018","MPP1",0,"Gene",43
"1019","MPP5",4,"Gene",83
"1020","mRNA Capping",0,"Pathway",43
"1021","mRNA Processing",0,"Pathway",43
"1022","mRNA Splicing",0,"Pathway",43
"1023","MRPL11",5,"Gene",85
"1024","MRPL12",5,"Gene",85
"1025","MRPL13",5,"Gene",85
"1026","MRPL19",6,"Gene",86
"1027","MRPL22",5,"Gene",85
"1028","MRPL4",5,"Gene",85
"1029","MRPS16",5,"Gene",85
"1030","MRPS2",0,"Gene",43
"1031","MRPS28",5,"Gene",85
"1032","MRPS35",5,"Gene",85
"1033","MRPS7",5,"Gene",85
"1034","MSMO1",4,"Gene",83
"1035","MTHFD2",4,"Gene",83
"1036","mTOR signaling pathway",0,"Pathway",43
"1037","mTOR signalling",0,"Pathway",43
"1038","mTORC1-mediated signalling",0,"Pathway",43
"1039","MUC1",5,"Gene",86
"1040","Muscarinic acetylcholine receptors",0,"Pathway",43
"1041","Muscle contraction",0,"Pathway",43
"1042","MVD",13,"Gene",93
"1043","MYC",82,"Gene",100
"1044","MyD88-independent cascade",0,"Pathway",43
"1045","MyD88 cascade initiated on plasma membrane",0,"Pathway",43
"1046","MyD88 dependent cascade initiated on endosome",0,"Pathway",43
"1047","MyD88:Mal cascade initiated on plasma membrane",0,"Pathway",43
"1048","MYLK",7,"Gene",88
"1049","Myometrial Relaxation and Contraction Pathways",0,"Pathway",43
"1050","N-cadherin signaling events",0,"Pathway",43
"1051","N-glycan trimming in the ER and Calnexin/Calreticulin cycle",0,"Pathway",43
"1052","Na+/Cl- dependent neurotransmitter transporters",0,"Pathway",44
"1053","NAA10",1,"Gene",79
"1054","NADE modulates death signalling",0,"Pathway",44
"1055","NCAM signaling for neurite out-growth",0,"Pathway",44
"1056","NCAM1 interactions",0,"Pathway",44
"1057","NCAPD2",7,"Gene",88
"1058","NCK2",26,"Gene",97
"1059","NCL",5,"Gene",86
"1060","NCOA1",45,"Gene",99
"1061","NDUFA10",6,"Gene",87
"1062","NDUFA13",6,"Gene",87
"1063","NDUFA9",6,"Gene",87
"1064","NDUFB8",6,"Gene",87
"1065","NDUFS3",6,"Gene",87
"1066","NDUFS6",6,"Gene",87
"1067","Nectin adhesion pathway",0,"Pathway",44
"1068","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters",0,"Pathway",44
"1069","Nef and signal transduction",0,"Pathway",44
"1070","Nef Mediated CD4 Down-regulation",0,"Pathway",44
"1071","Nef Mediated CD8 Down-regulation",0,"Pathway",44
"1072","Negative epigenetic regulation of rRNA expression",0,"Pathway",44
"1073","Negative regulation of FGFR signaling",0,"Pathway",44
"1074","Negative regulation of the PI3K/AKT network",0,"Pathway",44
"1075","Negative regulators of RIG-I/MDA5 signaling",0,"Pathway",44
"1076","NEP/NS2 Interacts with the Cellular Export Machinery",0,"Pathway",44
"1077","Nephrin interactions",0,"Pathway",44
"1078","Nephrin/Neph1 signaling in the kidney podocyte",0,"Pathway",44
"1079","Netrin-1 signaling",0,"Pathway",44
"1080","Netrin-mediated signaling events",0,"Pathway",44
"1081","Netrin mediated repulsion signals",0,"Pathway",44
"1082","Neural Crest Differentiation",0,"Pathway",45
"1083","Neurofascin interactions",0,"Pathway",45
"1084","Neuronal System",0,"Pathway",45
"1085","Neurotransmitter Clearance In The Synaptic Cleft",0,"Pathway",45
"1086","Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell",0,"Pathway",45
"1087","Neurotransmitter Release Cycle",0,"Pathway",45
"1088","Neurotrophic factor-mediated Trk receptor signaling",0,"Pathway",45
"1089","NF-kB is activated and signals survival",0,"Pathway",45
"1090","NFKB2",39,"Gene",98
"1091","NFKBIE",7,"Gene",88
"1092","NFX1",1,"Gene",79
"1093","NGF signalling via TRKA from the plasma membrane",0,"Pathway",45
"1094","NICD traffics to nucleus",0,"Pathway",45
"1095","Nicotinamide salvaging",0,"Pathway",45
"1096","Nicotinate metabolism",0,"Pathway",45
"1097","Nicotine Activity on Chromaffin Cells",0,"Pathway",45
"1098","Nicotine Activity on Dopaminergic Neurons",0,"Pathway",45
"1099","Nicotine Metabolism",0,"Pathway",45
"1100","NISCH",1,"Gene",79
"1101","NME1",10,"Gene",91
"1102","NNT",4,"Gene",83
"1103","NOD pathway",0,"Pathway",45
"1104","NOD1/2 Signaling Pathway",0,"Pathway",45
"1105","Non-coding RNA Metabolism",0,"Pathway",45
"1106","Non-homologous end joining",0,"Pathway",45
"1107","Non-integrin membrane-ECM interactions",0,"Pathway",46
"1108","Noncanonical Wnt signaling pathway",0,"Pathway",46
"1109","Nongenotropic Androgen signaling",0,"Pathway",46
"1110","Nonhomologous End-joining (NHEJ)",0,"Pathway",46
"1111","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",0,"Pathway",46
"1112","Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",0,"Pathway",46
"1113","NoRC negatively regulates rRNA expression",0,"Pathway",46
"1114","Norepinephrine Neurotransmitter Release Cycle",0,"Pathway",46
"1115","Nortriptyline",79,"Compound",100
"1116","NOSIP",3,"Gene",82
"1117","NOSIP mediated eNOS trafficking",0,"Pathway",46
"1118","Notch-mediated HES/HEY network",0,"Pathway",46
"1119","Notch signaling pathway",0,"Pathway",46
"1120","Notch signaling pathway",0,"BiologicalProcess",46
"1121","Notch Signaling Pathway",0,"Pathway",46
"1122","Notch Signaling Pathway",0,"Pathway",46
"1123","Notch Signaling Pathway",0,"Pathway",46
"1124","Notch Signaling Pathway",0,"Pathway",46
"1125","NOTCH1",38,"Gene",98
"1126","NOTCH1 Intracellular Domain Regulates Transcription",0,"Pathway",46
"1127","NOTCH1 regulation of human endothelial cell calcification",0,"Pathway",46
"1128","NOTCH2",18,"Gene",95
"1129","NOTCH2 Activation and Transmission of Signal to the Nucleus",0,"Pathway",46
"1130","NOTCH2 intracellular domain regulates transcription",0,"Pathway",47
"1131","NOV",0,"Gene",47
"1132","NPAT",1,"Gene",79
"1133","NPC1",1,"Gene",79
"1134","NPDC1",0,"Gene",47
"1135","NPR3",0,"Gene",47
"1136","NPTX2",0,"Gene",47
"1137","NQO1",12,"Gene",92
"1138","NR3C1",17,"Gene",95
"1139","NRAGE signals death through JNK",0,"Pathway",47
"1140","NRF2 pathway",0,"Pathway",47
"1141","NRIF signals cell death from the nucleus",0,"Pathway",47
"1142","NSDHL",4,"Gene",83
"1143","NT5C",6,"Gene",87
"1144","NUBP2",2,"Gene",80
"1145","Nuclear Envelope Breakdown",0,"Pathway",47
"1146","Nuclear import of Rev protein",0,"Pathway",47
"1147","Nuclear Pore Complex (NPC) Disassembly",0,"Pathway",47
"1148","Nuclear Receptor transcription pathway",0,"Pathway",47
"1149","Nuclear Receptors",0,"Pathway",47
"1150","Nuclear Receptors in Lipid Metabolism and Toxicity",0,"Pathway",47
"1151","Nuclear signaling by ERBB4",0,"Pathway",47
"1152","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0,"Pathway",47
"1153","Nucleotide Excision Repair",0,"Pathway",47
"1154","Nucleotide metabolism",0,"Pathway",47
"1155","Nucleotide Metabolism",0,"Pathway",47
"1156","NUDC",12,"Gene",92
"1157","NUDT1",3,"Gene",82
"1158","NUDT6",0,"Gene",48
"1159","NUP85",53,"Gene",100
"1160","O-linked glycosylation",0,"Pathway",48
"1161","O-linked glycosylation of mucins",0,"Pathway",48
"1162","Oligomerization of connexins into connexons",0,"Pathway",48
"1163","Oncogene Induced Senescence",0,"Pathway",48
"1164","Oncostatin M Signaling Pathway",0,"Pathway",48
"1165","One Carbon Metabolism",0,"Pathway",48
"1166","Opioid Signalling",0,"Pathway",48
"1167","Orc1 removal from chromatin",0,"Pathway",48
"1168","Organelle biogenesis and maintenance",0,"Pathway",48
"1169","Organic cation transport",0,"Pathway",48
"1170","Organic cation/anion/zwitterion transport",0,"Pathway",48
"1171","ORM1",0,"Gene",48
"1172","Orphan transporters",0,"Pathway",48
"1173","Osteoblast Signaling",0,"Pathway",48
"1174","Osteoclast Signaling",0,"Pathway",48
"1175","Osteopontin-mediated events",0,"Pathway",48
"1176","Osteopontin Signaling",0,"Pathway",48
"1177","OTUB1",0,"Gene",48
"1178","Ovarian Infertility Genes",0,"Pathway",49
"1179","Overview of nanoparticle effects",0,"Pathway",49
"1180","OXA1L",0,"Gene",49
"1181","Oxidation by Cytochrome P450",0,"Pathway",49
"1182","Oxidative phosphorylation",0,"Pathway",49
"1183","Oxidative Stress",0,"Pathway",49
"1184","Oxidative Stress Induced Senescence",0,"Pathway",49
"1185","OXSR1",0,"Gene",49
"1186","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha",0,"Pathway",49
"1187","p130Cas linkage to MAPK signaling for integrins",0,"Pathway",49
"1188","p38 MAPK signaling pathway",0,"Pathway",49
"1189","p38 MAPK Signaling Pathway",0,"Pathway",49
"1190","p38 signaling mediated by MAPKAP kinases",0,"Pathway",49
"1191","p38MAPK events",0,"Pathway",49
"1192","p53-Dependent G1 DNA Damage Response",0,"Pathway",49
"1193","p53 pathway",0,"Pathway",49
"1194","p73 transcription factor network",0,"Pathway",49
"1195","p75 NTR receptor-mediated signalling",0,"Pathway",49
"1196","p75(NTR)-mediated signaling",0,"Pathway",49
"1197","p75NTR negatively regulates cell cycle via SC1",0,"Pathway",50
"1198","p75NTR recruits signalling complexes",0,"Pathway",50
"1199","p75NTR signals via NF-kB",0,"Pathway",50
"1200","Packaging Of Telomere Ends",0,"Pathway",50
"1201","PAFAH1B3",1,"Gene",79
"1202","PAK1",55,"Gene",100
"1203","PAK6",8,"Gene",90
"1204","PAR1-mediated thrombin signaling events",0,"Pathway",50
"1205","PARD3",8,"Gene",90
"1206","PARK7",4,"Gene",83
"1207","Parkin-Ubiquitin Proteasomal System pathway",0,"Pathway",50
"1208","Parkinsons Disease Pathway",0,"Pathway",50
"1209","Pathogenic Escherichia coli infection",0,"Pathway",50
"1210","Pausing and recovery of Tat-mediated HIV elongation",0,"Pathway",50
"1211","PAX8",2,"Gene",80
"1212","PCBD1",3,"Gene",82
"1213","PCNA",44,"Gene",99
"1214","PCP/CE pathway",0,"Pathway",50
"1215","PD-1 signaling",0,"Pathway",50
"1216","PDGF Pathway",0,"Pathway",50
"1217","PDGFR-alpha signaling pathway",0,"Pathway",50
"1218","PDGFR-beta signaling pathway",0,"Pathway",50
"1219","PDIA5",4,"Gene",83
"1220","PECAM1 interactions",0,"Pathway",50
"1221","Pentose Phosphate Pathway",0,"Pathway",50
"1222","Peptide chain elongation",0,"Pathway",50
"1223","Peptide hormone metabolism",0,"Pathway",50
"1224","Peptide ligand-binding receptors",0,"Pathway",50
"1225","PER3",2,"Gene",80
"1226","PF4",16,"Gene",95
"1227","PFKL",8,"Gene",90
"1228","PFN1",13,"Gene",93
"1229","PGLS",4,"Gene",83
"1230","Phase 1 - Functionalization of compounds",0,"Pathway",51
"1231","Phase I biotransformations, non P450",0,"Pathway",51
"1232","Phase II conjugation",0,"Pathway",51
"1233","Phenylalanine and tyrosine catabolism",0,"Pathway",51
"1234","PHIP",0,"Gene",51
"1235","Phosphate bond hydrolysis by NUDT proteins",0,"Pathway",51
"1236","Phospholipase C-mediated cascade",0,"Pathway",51
"1237","Phospholipid metabolism",0,"Pathway",51
"1238","Phosphorylation of CD3 and TCR zeta chains",0,"Pathway",51
"1239","Phosphorylation of Emi1",0,"Pathway",51
"1240","Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes",0,"Pathway",51
"1241","Phosphorylation of the APC/C",0,"Pathway",51
"1242","PI-3K cascade",0,"Pathway",51
"1243","PI Metabolism",0,"Pathway",51
"1244","PI3K Cascade",0,"Pathway",51
"1245","PI3K/AKT activation",0,"Pathway",51
"1246","PIKFYVE",7,"Gene",88
"1247","PIP4K2A",7,"Gene",88
"1248","PIP5K1B",19,"Gene",96
"1249","PKA activation in glucagon signalling",0,"Pathway",51
"1250","PKB-mediated events",0,"Pathway",51
"1251","PKIG",2,"Gene",80
"1252","PLA2G15",0,"Gene",51
"1253","Plasma membrane estrogen receptor signaling",0,"Pathway",52
"1254","Platelet activation, signaling and aggregation",0,"Pathway",52
"1255","Platelet Adhesion to exposed collagen",0,"Pathway",52
"1256","Platelet Aggregation (Plug Formation)",0,"Pathway",52
"1257","Platelet degranulation",0,"Pathway",52
"1258","Platelet homeostasis",0,"Pathway",52
"1259","Platelet sensitization by LDL",0,"Pathway",52
"1260","PLC beta mediated events",0,"Pathway",52
"1261","PLEKHM1",0,"Gene",52
"1262","Plexin-D1 Signaling",0,"Pathway",52
"1263","PLK1 signaling events",0,"Pathway",52
"1264","PLP1",2,"Gene",80
"1265","PLS1",0,"Gene",52
"1266","PMM2",6,"Gene",87
"1267","PNKP",1,"Gene",79
"1268","PNP",5,"Gene",86
"1269","PNPLA3",7,"Gene",88
"1270","POLD4",29,"Gene",97
"1271","POLR1D",23,"Gene",96
"1272","Porphyrin metabolism",0,"Pathway",52
"1273","Post-chaperonin tubulin folding pathway",0,"Pathway",52
"1274","Post-Elongation Processing of Intron-Containing pre-mRNA",0,"Pathway",52
"1275","Post-translational protein modification",0,"Pathway",52
"1276","Posttranslational regulation of adherens junction stability and dissassembly",0,"Pathway",52
"1277","PPAR Alpha Pathway",0,"Pathway",52
"1278","PPARA activates gene expression",0,"Pathway",52
"1279","PPARD",19,"Gene",96
"1280","PPARGC1A",29,"Gene",97
"1281","PPIB",4,"Gene",83
"1282","PPM1G",1,"Gene",79
"1283","PPP2R5E",29,"Gene",98
"1284","PPP4C",0,"Gene",53
"1285","PRC2 methylates histones and DNA",0,"Pathway",53
"1286","PRCP",3,"Gene",82
"1287","Pre-NOTCH Expression and Processing",0,"Pathway",53
"1288","Pre-NOTCH Processing in Golgi",0,"Pathway",53
"1289","Pre-NOTCH Processing in the Endoplasmic Reticulum",0,"Pathway",53
"1290","Pre-NOTCH Transcription and Translation",0,"Pathway",53
"1291","Prefoldin mediated transfer of substrate to CCT/TriC",0,"Pathway",53
"1292","Preimplantation Embryo",0,"Pathway",53
"1293","Presenilin action in Notch and Wnt signaling",0,"Pathway",53
"1294","Presynaptic nicotinic acetylcholine receptors",0,"Pathway",53
"1295","Presynaptic phase of homologous DNA pairing and strand exchange",0,"Pathway",53
"1296","Primary Focal Segmental Glomerulosclerosis FSGS",0,"Pathway",53
"1297","PRKAG2",28,"Gene",97
"1298","PRKCQ",44,"Gene",99
"1299","Processing of Capped Intron-Containing Pre-mRNA",0,"Pathway",53
"1300","Processing of DNA double-strand break ends",0,"Pathway",53
"1301","Processing of DNA ends prior to end rejoining",0,"Pathway",53
"1302","Processive synthesis on the C-strand of the telomere",0,"Pathway",53
"1303","Processive synthesis on the lagging strand",0,"Pathway",53
"1304","PROCR",4,"Gene",83
"1305","Prolactin receptor signaling",0,"Pathway",53
"1306","Prolonged ERK activation events",0,"Pathway",53
"1307","PROS1",19,"Gene",96
"1308","Prostacyclin signalling through prostacyclin receptor",0,"Pathway",54
"1309","Prostaglandin Synthesis and Regulation",0,"Pathway",54
"1310","Proteasome Degradation",0,"Pathway",54
"1311","Protein folding",0,"Pathway",54
"1312","Proteoglycan syndecan-mediated signaling events",0,"Pathway",54
"1313","PRPF18",1,"Gene",79
"1314","PRUNE",0,"Gene",54
"1315","PRUNE2",0,"Gene",54
"1316","PSD4",0,"Gene",54
"1317","PSMA7",83,"Gene",100
"1318","PSMB2",83,"Gene",100
"1319","PSMB6",83,"Gene",100
"1320","PSMC3",84,"Gene",100
"1321","PSME1",83,"Gene",100
"1322","PSMG1",0,"Gene",54
"1323","PTGS1",10,"Gene",91
"1324","PTGS2",22,"Gene",96
"1325","PTM: gamma carboxylation, hypusine formation and arylsulfatase activation",0,"Pathway",54
"1326","PTPN6",41,"Gene",99
"1327","PTPRK",1,"Gene",79
"1328","PTPRO",2,"Gene",80
"1329","PUF60",0,"Gene",54
"1330","Purine catabolism",0,"Pathway",54
"1331","Purine metabolism",0,"Pathway",54
"1332","Purine ribonucleoside monophosphate biosynthesis",0,"Pathway",54
"1333","Purine salvage",0,"Pathway",54
"1334","PWP2",0,"Gene",54
"1335","PYCR1",4,"Gene",84
"1336","Pyrimidine biosynthesis",0,"Pathway",54
"1337","Pyrimidine catabolism",0,"Pathway",54
"1338","Pyrimidine metabolism",0,"Pathway",54
"1339","Pyrimidine salvage reactions",0,"Pathway",55
"1340","Pyruvate metabolism",0,"Pathway",55
"1341","Pyruvate metabolism and Citric Acid (TCA) cycle",0,"Pathway",55
"1342","Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis",0,"Pathway",55
"1343","RAC1 signaling pathway",0,"Pathway",55
"1344","Rac1/Pak1/p38/MMP-2 pathway",0,"Pathway",55
"1345","RAI14",0,"Gene",55
"1346","RalA downstream regulated genes",0,"Pathway",55
"1347","RALB",10,"Gene",91
"1348","RAN",28,"Gene",97
"1349","RANKL/RANK Signaling Pathway",0,"Pathway",55
"1350","RBM6",0,"Gene",55
"1351","Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor",0,"Pathway",55
"1352","RECK",0,"Gene",55
"1353","Recycling of bile acids and salts",0,"Pathway",55
"1354","Recycling pathway of L1",0,"Pathway",55
"1355","Reelin signaling pathway",0,"Pathway",55
"1356","Regulation of Actin Cytoskeleton",0,"Pathway",55
"1357","Regulation of actin dynamics for phagocytic cup formation",0,"Pathway",55
"1358","Regulation of activated PAK-2p34 by proteasome mediated degradation",0,"Pathway",55
"1359","Regulation of AMPK activity via LKB1",0,"Pathway",55
"1360","Regulation of Androgen receptor activity",0,"Pathway",56
"1361","Regulation of APC/C activators between G1/S and early anaphase",0,"Pathway",56
"1362","Regulation of Apoptosis",0,"Pathway",56
"1363","Regulation of beta-cell development",0,"Pathway",56
"1364","Regulation of CDC42 activity",0,"Pathway",56
"1365","Regulation of cholesterol biosynthesis by SREBP (SREBF)",0,"Pathway",56
"1366","Regulation of Complement cascade",0,"Pathway",56
"1367","Regulation of cytoplasmic and nuclear SMAD2/3 signaling",0,"Pathway",56
"1368","Regulation of cytoskeletal remodeling and cell spreading by IPP complex components",0,"Pathway",56
"1369","Regulation of DNA replication",0,"Pathway",56
"1370","regulation of FZD by ubiquitination",0,"Pathway",56
"1371","Regulation of gap junction activity",0,"Pathway",56
"1372","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells",0,"Pathway",56
"1373","Regulation of Glucokinase by Glucokinase Regulatory Protein",0,"Pathway",56
"1374","Regulation of HSF1-mediated heat shock response",0,"Pathway",56
"1375","Regulation of IFNA signaling",0,"Pathway",56
"1376","Regulation of IFNG signaling",0,"Pathway",56
"1377","Regulation of innate immune responses to cytosolic DNA",0,"Pathway",56
"1378","Regulation of insulin secretion",0,"Pathway",56
"1379","Regulation of KIT signaling",0,"Pathway",57
"1380","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)",0,"Pathway",57
"1381","Regulation of mRNA stability by proteins that bind AU-rich elements",0,"Pathway",57
"1382","Regulation of nuclear beta catenin signaling and target gene transcription",0,"Pathway",57
"1383","Regulation of nuclear SMAD2/3 signaling",0,"Pathway",57
"1384","Regulation of ornithine decarboxylase (ODC)",0,"Pathway",57
"1385","Regulation of p38-alpha and p38-beta",0,"Pathway",57
"1386","Regulation of PLK1 Activity at G2/M Transition",0,"Pathway",57
"1387","Regulation of pyruvate dehydrogenase (PDH) complex",0,"Pathway",57
"1388","Regulation of RAC1 activity",0,"Pathway",57
"1389","Regulation of retinoblastoma protein",0,"Pathway",57
"1390","Regulation of Rheb GTPase activity by AMPK",0,"Pathway",57
"1391","Regulation of RhoA activity",0,"Pathway",57
"1392","Regulation of signaling by CBL",0,"Pathway",57
"1393","Regulation of Telomerase",0,"Pathway",57
"1394","Regulation of the Fanconi anemia pathway",0,"Pathway",57
"1395","Regulation of toll-like receptor signaling pathway",0,"Pathway",57
"1396","Regulatory RNA pathways",0,"Pathway",57
"1397","Release of apoptotic factors from the mitochondria",0,"Pathway",58
"1398","Removal of aminoterminal propeptides from gamma-carboxylated proteins",0,"Pathway",58
"1399","Removal of DNA patch containing abasic residue",0,"Pathway",58
"1400","Removal of licensing factors from origins",0,"Pathway",58
"1401","Removal of the Flap Intermediate",0,"Pathway",58
"1402","Removal of the Flap Intermediate from the C-strand",0,"Pathway",58
"1403","Repair synthesis for gap-filling by DNA polymerase in TC-NER",0,"Pathway",58
"1404","Resolution of AP sites via the single-nucleotide replacement pathway",0,"Pathway",58
"1405","Resolution of D-loop structures",0,"Pathway",58
"1406","Resolution of Sister Chromatid Cohesion",0,"Pathway",58
"1407","Respiratory electron transport",0,"Pathway",58
"1408","Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0,"Pathway",58
"1409","Response to elevated platelet cytosolic Ca2+",0,"Pathway",58
"1410","Retinoblastoma (RB) in Cancer",0,"Pathway",58
"1411","Retinoic acid receptors-mediated signaling",0,"Pathway",58
"1412","Retinoid metabolism and transport",0,"Pathway",58
"1413","Retrograde neurotrophin signalling",0,"Pathway",58
"1414","REV-ERBA represses gene expression",0,"Pathway",58
"1415","Rev-mediated nuclear export of HIV RNA",0,"Pathway",59
"1416","REV3L",0,"Gene",59
"1417","RGS2",7,"Gene",88
"1418","Rho GTPase cycle",0,"Pathway",59
"1419","RhoA signaling pathway",0,"Pathway",59
"1420","RHOT2",2,"Gene",80
"1421","Ribosomal scanning and start codon recognition",0,"Pathway",59
"1422","RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways",0,"Pathway",59
"1423","RIN3",0,"Gene",59
"1424","RIP-mediated NFkB activation via ZBP1",0,"Pathway",59
"1425","RMI1",1,"Gene",79
"1426","RMTs methylate histone arginines",0,"Pathway",59
"1427","RNA Pol II CTD phosphorylation and interaction with CE",0,"Pathway",59
"1428","RNA Polymerase I Chain Elongation",0,"Pathway",59
"1429","RNA Polymerase I Promoter Clearance",0,"Pathway",59
"1430","RNA Polymerase I Promoter Escape",0,"Pathway",59
"1431","RNA Polymerase I Promoter Opening",0,"Pathway",59
"1432","RNA Polymerase I Transcription",0,"Pathway",59
"1433","RNA Polymerase I Transcription Initiation",0,"Pathway",59
"1434","RNA Polymerase I Transcription Termination",0,"Pathway",59
"1435","RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription",0,"Pathway",59
"1436","RNA Polymerase II Pre-transcription Events",0,"Pathway",60
"1437","RNA Polymerase II Transcription",0,"Pathway",60
"1438","RNA Polymerase III Abortive And Retractive Initiation",0,"Pathway",60
"1439","RNA Polymerase III Chain Elongation",0,"Pathway",60
"1440","RNA Polymerase III Transcription Initiation",0,"Pathway",60
"1441","RNA Polymerase III Transcription Initiation From Type 1 Promoter",0,"Pathway",60
"1442","RNA Polymerase III Transcription Initiation From Type 2 Promoter",0,"Pathway",60
"1443","RNA Polymerase III Transcription Initiation From Type 3 Promoter",0,"Pathway",60
"1444","RNA Polymerase III Transcription Termination",0,"Pathway",60
"1445","RNF mutants show enhanced WNT signaling and proliferation",0,"Pathway",60
"1446","RNPS1",13,"Gene",93
"1447","Role of Calcineurin-dependent NFAT signaling in lymphocytes",0,"Pathway",60
"1448","Role of DCC in regulating apoptosis",0,"Pathway",60
"1449","Role of LAT2/NTAL/LAB on calcium mobilization",0,"Pathway",60
"1450","Role of phospholipids in phagocytosis",0,"Pathway",60
"1451","RORA activates circadian gene expression",0,"Pathway",60
"1452","RPA3",48,"Gene",99
"1453","RPN1",7,"Gene",89
"1454","RPS4Y1",25,"Gene",97
"1455","RPS6",51,"Gene",99
"1456","RPS6KC1",0,"Gene",60
"1457","RRAGD",2,"Gene",80
"1458","RRP1B",0,"Gene",60
"1459","RRP8",4,"Gene",84
"1460","RSU1",4,"Gene",84
"1461","RUVBL1",19,"Gene",96
"1462","RXR and RAR heterodimerization with other nuclear receptor",0,"Pathway",60
"1463","S Phase",0,"Pathway",61
"1464","S100A4",0,"Gene",61
"1465","S1P1 pathway",0,"Pathway",61
"1466","S1P2 pathway",0,"Pathway",61
"1467","S1P3 pathway",0,"Pathway",61
"1468","S1P4 pathway",0,"Pathway",61
"1469","S1P5 pathway",0,"Pathway",61
"1470","S6K1-mediated signalling",0,"Pathway",61
"1471","S6K1 signalling",0,"Pathway",61
"1472","SATB1",4,"Gene",84
"1473","SC5D",6,"Gene",87
"1474","SCAPER",0,"Gene",61
"1475","Scavenging by Class F Receptors",0,"Pathway",61
"1476","Scavenging of heme from plasma",0,"Pathway",61
"1477","SCD",5,"Gene",86
"1478","SCF-beta-TrCP mediated degradation of Emi1",0,"Pathway",61
"1479","SCF(Skp2)-mediated degradation of p27/p21",0,"Pathway",61
"1480","SCN1B",4,"Gene",84
"1481","SCYL3",0,"Gene",61
"1482","SDC1",24,"Gene",97
"1483","SDCBP",11,"Gene",92
"1484","SDHB",8,"Gene",90
"1485","Secretion of Hydrochloric Acid in Parietal Cells",0,"Pathway",61
"1486","Selenium Metabolism and Selenoproteins",0,"Pathway",61
"1487","Selenium Micronutrient Network",0,"Pathway",61
"1488","SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion",0,"Pathway",62
"1489","Sema3A PAK dependent Axon repulsion",0,"Pathway",62
"1490","Semaphorin interactions",0,"Pathway",62
"1491","Senescence-Associated Secretory Phenotype (SASP)",0,"Pathway",62
"1492","Senescence and Autophagy in Cancer",0,"Pathway",62
"1493","Separation of Sister Chromatids",0,"Pathway",62
"1494","SEPHS2",2,"Gene",80
"1495","Serotonin Receptor 2 and ELK-SRF/GATA4 signaling",0,"Pathway",62
"1496","Serotonin Receptor 2 and STAT3 Signaling",0,"Pathway",62
"1497","Serotonin Receptor 4/6/7 and NR3C Signaling",0,"Pathway",62
"1498","Serotonin receptors",0,"Pathway",62
"1499","Serotonin Transporter Activity",0,"Pathway",62
"1500","SERPINA3",3,"Gene",82
"1501","SESN1",3,"Gene",82
"1502","SGMS1",5,"Gene",86
"1503","SHC-mediated cascade",0,"Pathway",62
"1504","SHC-mediated signalling",0,"Pathway",62
"1505","SHC-related events",0,"Pathway",62
"1506","SHC-related events triggered by IGF1R",0,"Pathway",62
"1507","SHC activation",0,"Pathway",62
"1508","SHC1",115,"Gene",100
"1509","SHC1 events in EGFR signaling",0,"Pathway",62
"1510","SHC1 events in ERBB2 signaling",0,"Pathway",62
"1511","SHC1 events in ERBB4 signaling",0,"Pathway",63
"1512","SHP2 signaling",0,"Pathway",63
"1513","SIDS Susceptibility Pathways",0,"Pathway",63
"1514","Signal amplification",0,"Pathway",63
"1515","Signal attenuation",0,"Pathway",63
"1516","Signal regulatory protein (SIRP) family interactions",0,"Pathway",63
"1517","Signal transduction by L1",0,"Pathway",63
"1518","Signal Transduction of S1P Receptor",0,"Pathway",63
"1519","Signaling by Activin",0,"Pathway",63
"1520","Signaling by Aurora kinases",0,"Pathway",63
"1521","Signaling by constitutively active EGFR",0,"Pathway",63
"1522","Signaling by EGFR",0,"Pathway",63
"1523","Signaling by EGFR in Cancer",0,"Pathway",63
"1524","Signaling by ERBB2",0,"Pathway",63
"1525","Signaling by ERBB4",0,"Pathway",63
"1526","Signaling by FGFR",0,"Pathway",63
"1527","Signaling by FGFR in disease",0,"Pathway",63
"1528","Signaling by FGFR mutants",0,"Pathway",63
"1529","Signaling by FGFR1 fusion mutants",0,"Pathway",64
"1530","Signaling by FGFR1 mutants",0,"Pathway",64
"1531","Signaling by GPCR",0,"Pathway",64
"1532","Signaling by Hedgehog",0,"Pathway",64
"1533","Signaling by Hippo",0,"Pathway",64
"1534","Signaling by Insulin receptor",0,"Pathway",64
"1535","Signaling by Interleukins",0,"Pathway",64
"1536","Signaling by Leptin",0,"Pathway",64
"1537","Signaling by NGF",0,"Pathway",64
"1538","Signaling by NODAL",0,"Pathway",64
"1539","Signaling by NOTCH",0,"Pathway",64
"1540","Signaling by NOTCH2",0,"Pathway",64
"1541","Signaling by NOTCH3",0,"Pathway",64
"1542","Signaling by NOTCH4",0,"Pathway",64
"1543","Signaling by PDGF",0,"Pathway",64
"1544","Signaling by Robo receptor",0,"Pathway",64
"1545","Signaling by SCF-KIT",0,"Pathway",64
"1546","Signaling by VEGF",0,"Pathway",64
"1547","Signaling by Wnt",0,"Pathway",65
"1548","Signaling by WNT in cancer",0,"Pathway",65
"1549","Signaling events mediated by focal adhesion kinase",0,"Pathway",65
"1550","Signaling events mediated by HDAC Class I",0,"Pathway",65
"1551","Signaling events mediated by HDAC Class II",0,"Pathway",65
"1552","Signaling events mediated by HDAC Class III",0,"Pathway",65
"1553","Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)",0,"Pathway",65
"1554","Signaling events mediated by PRL",0,"Pathway",65
"1555","Signaling events mediated by PTP1B",0,"Pathway",65
"1556","Signaling events mediated by Stem cell factor receptor (c-Kit)",0,"Pathway",65
"1557","Signaling events mediated by TCPTP",0,"Pathway",65
"1558","Signaling events mediated by VEGFR1 and VEGFR2",0,"Pathway",65
"1559","Signaling events regulated by Ret tyrosine kinase",0,"Pathway",65
"1560","Signaling mediated by p38-alpha and p38-beta",0,"Pathway",65
"1561","Signaling of Hepatocyte Growth Factor Receptor",0,"Pathway",65
"1562","Signaling Pathways",0,"Pathway",65
"1563","Signaling Pathways in Glioblastoma",0,"Pathway",65
"1564","Signalling to ERKs",0,"Pathway",65
"1565","Signalling to RAS",0,"Pathway",66
"1566","SIK3",1,"Gene",79
"1567","SIPA1L1",0,"Gene",66
"1568","SIRT1 negatively regulates rRNA Expression",0,"Pathway",66
"1569","SLC-mediated transmembrane transport",0,"Pathway",66
"1570","SLC19A2",4,"Gene",84
"1571","SLC22A1",15,"Gene",94
"1572","SLC22A3",9,"Gene",90
"1573","SLC22A4",5,"Gene",86
"1574","SLC22A5",5,"Gene",86
"1575","SLC25A4",13,"Gene",93
"1576","SLC25A6",14,"Gene",94
"1577","SLC2A6",5,"Gene",86
"1578","SLC35F2",0,"Gene",66
"1579","SLC38A1",9,"Gene",91
"1580","SLC43A3",0,"Gene",66
"1581","SLC6A2",7,"Gene",89
"1582","SLC6A3",14,"Gene",94
"1583","SLC6A4",6,"Gene",87
"1584","SLC6A6",9,"Gene",91
"1585","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription",0,"Pathway",66
"1586","SMARCA2",6,"Gene",87
"1587","SMCHD1",0,"Gene",66
"1588","Smooth Muscle Contraction",0,"Pathway",66
"1589","SNRPA",4,"Gene",84
"1590","SNRPA1",4,"Gene",84
"1591","SNRPD2",7,"Gene",89
"1592","SNX19",0,"Gene",66
"1593","SNX6",0,"Gene",66
"1594","SOCS5",2,"Gene",81
"1595","SON",0,"Gene",66
"1596","SOX10",1,"Gene",79
"1597","SPG11",0,"Gene",66
"1598","Sphingolipid de novo biosynthesis",0,"Pathway",66
"1599","Sphingolipid metabolism",0,"Pathway",66
"1600","Sphingolipid Metabolism",0,"Pathway",66
"1601","Sphingosine 1-phosphate (S1P) pathway",0,"Pathway",66
"1602","Spinal Cord Injury",0,"Pathway",66
"1603","SPR",3,"Gene",82
"1604","Spry regulation of FGF signaling",0,"Pathway",67
"1605","SPTLC2",5,"Gene",86
"1606","SQLE",8,"Gene",90
"1607","SQSTM1",23,"Gene",97
"1608","SREBF and miR33 in cholesterol and lipid homeostasis",0,"Pathway",67
"1609","SREBF2",11,"Gene",92
"1610","SREBP signalling",0,"Pathway",67
"1611","SRP-dependent cotranslational protein targeting to membrane",0,"Pathway",67
"1612","SS18L1",0,"Gene",67
"1613","ST7",0,"Gene",67
"1614","Stabilization and expansion of the E-cadherin adherens junction",0,"Pathway",67
"1615","Stabilization of p53",0,"Pathway",67
"1616","STAM2",9,"Gene",91
"1617","STAT5A",60,"Gene",100
"1618","STAT5B",52,"Gene",100
"1619","Statin Pathway",0,"Pathway",67
"1620","Steroid Biosynthesis",0,"Pathway",67
"1621","Stimuli-sensing channels",0,"Pathway",67
"1622","STING mediated induction of host immune responses",0,"Pathway",67
"1623","STOML2",0,"Gene",67
"1624","Structural Pathway of Interleukin 1 (IL-1)",0,"Pathway",67
"1625","STUB1",13,"Gene",93
"1626","STXBP1",15,"Gene",94
"1627","Sulfation Biotransformation Reaction",0,"Pathway",67
"1628","Sulfur amino acid metabolism",0,"Pathway",67
"1629","Sulindac Metabolic Pathway",0,"Pathway",67
"1630","Sumoylation by RanBP2 regulates transcriptional repression",0,"Pathway",67
"1631","SUV39H1",8,"Gene",90
"1632","SUZ12",7,"Gene",89
"1633","SVIL",1,"Gene",79
"1634","SYK",42,"Gene",99
"1635","Synaptic Vesicle Pathway",0,"Pathway",68
"1636","Syndecan-1-mediated signaling events",0,"Pathway",68
"1637","Syndecan-2-mediated signaling events",0,"Pathway",68
"1638","Syndecan-3-mediated signaling events",0,"Pathway",68
"1639","Syndecan-4-mediated signaling events",0,"Pathway",68
"1640","Syndecan interactions",0,"Pathway",68
"1641","SYNGR3",0,"Gene",68
"1642","SYNJ1",11,"Gene",92
"1643","SYNJ2BP",0,"Gene",68
"1644","Synthesis and interconversion of nucleotide di- and triphosphates",0,"Pathway",68
"1645","Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)",0,"Pathway",68
"1646","Synthesis of 15-eicosatetraenoic acid derivatives",0,"Pathway",68
"1647","Synthesis of bile acids and bile salts",0,"Pathway",68
"1648","Synthesis of bile acids and bile salts via 27-hydroxycholesterol",0,"Pathway",68
"1649","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",0,"Pathway",68
"1650","Synthesis of DNA",0,"Pathway",68
"1651","Synthesis of Dolichyl-phosphate",0,"Pathway",68
"1652","Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)",0,"Pathway",68
"1653","Synthesis of GDP-mannose",0,"Pathway",68
"1654","Synthesis of IP2, IP, and Ins in the cytosol",0,"Pathway",69
"1655","Synthesis of IP3 and IP4 in the cytosol",0,"Pathway",69
"1656","Synthesis of PIPs at the early endosome membrane",0,"Pathway",69
"1657","Synthesis of PIPs at the Golgi membrane",0,"Pathway",69
"1658","Synthesis of PIPs at the late endosome membrane",0,"Pathway",69
"1659","Synthesis of PIPs at the plasma membrane",0,"Pathway",69
"1660","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)",0,"Pathway",69
"1661","Synthesis of substrates in N-glycan biosythesis",0,"Pathway",69
"1662","Synthesis of very long-chain fatty acyl-CoAs",0,"Pathway",69
"1663","T-Cell Receptor and Co-stimulatory Signaling",0,"Pathway",69
"1664","TAB2",47,"Gene",99
"1665","TAF4",10,"Gene",91
"1666","TAK1 activates NFkB by phosphorylation and activation of IKKs complex",0,"Pathway",69
"1667","Tamoxifen metabolism",0,"Pathway",69
"1668","TarBasePathway",0,"Pathway",69
"1669","TATDN2",4,"Gene",84
"1670","TBC1D19",0,"Gene",69
"1671","TBX2",2,"Gene",81
"1672","TCA Cycle",0,"Pathway",69
"1673","TCA Cycle and PDHc",0,"Pathway",69
"1674","TCEB2",25,"Gene",97
"1675","TCF dependent signaling in response to WNT",0,"Pathway",69
"1676","TCR signaling",0,"Pathway",69
"1677","TCR signaling in naïve CD4+ T cells",0,"Pathway",70
"1678","TCR signaling in naïve CD8+ T cells",0,"Pathway",70
"1679","TCR Signaling Pathway",0,"Pathway",70
"1680","TCTA",0,"Gene",70
"1681","TECPR2",0,"Gene",70
"1682","Telomere C-strand (Lagging Strand) Synthesis",0,"Pathway",70
"1683","Telomere Extension By Telomerase",0,"Pathway",70
"1684","Telomere Maintenance",0,"Pathway",70
"1685","Termination of O-glycan biosynthesis",0,"Pathway",70
"1686","Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",0,"Pathway",70
"1687","TFEB",0,"Gene",70
"1688","TGF-beta receptor signaling",0,"Pathway",70
"1689","TGF-beta Receptor Signaling",0,"Pathway",70
"1690","TGF-beta receptor signaling activates SMADs",0,"Pathway",70
"1691","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)",0,"Pathway",70
"1692","TGF-beta Signaling Pathway",0,"Pathway",70
"1693","THAP11",0,"Gene",70
"1694","The citric acid (TCA) cycle and respiratory electron transport",0,"Pathway",70
"1695","The NLRP1 inflammasome",0,"Pathway",71
"1696","The NLRP3 inflammasome",0,"Pathway",71
"1697","The phototransduction cascade",0,"Pathway",71
"1698","The role of Nef in HIV-1 replication and disease pathogenesis",0,"Pathway",71
"1699","Thromboxane A2 receptor signaling",0,"Pathway",71
"1700","Tie2 Signaling",0,"Pathway",71
"1701","Tight junction interactions",0,"Pathway",71
"1702","TIMELESS",3,"Gene",82
"1703","TIMM22",2,"Gene",81
"1704","TIMM9",2,"Gene",81
"1705","TIMP1",12,"Gene",92
"1706","TJP2",7,"Gene",89
"1707","TK1",7,"Gene",89
"1708","TKT",6,"Gene",87
"1709","TM9SF3",0,"Gene",71
"1710","TMEM109",0,"Gene",71
"1711","TMEM50A",0,"Gene",71
"1712","TMEM97",0,"Gene",71
"1713","TMSB10",0,"Gene",71
"1714","TNF alpha Signaling Pathway",0,"Pathway",71
"1715","TNF receptor signaling pathway ",0,"Pathway",71
"1716","Toll-like Receptor Signaling Pathway",0,"Pathway",71
"1717","Toll-Like Receptors Cascades",0,"Pathway",71
"1718","Toll Like Receptor 4 (TLR4) Cascade",0,"Pathway",71
"1719","Toll Like Receptor 9 (TLR9) Cascade",0,"Pathway",71
"1720","TOR Signaling",0,"Pathway",72
"1721","TP53 Network",0,"Pathway",72
"1722","TPI1",9,"Gene",91
"1723","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0,"Pathway",72
"1724","TRAF6 Mediated Induction of proinflammatory cytokines",0,"Pathway",72
"1725","TRAF6 mediated induction of TAK1 complex",0,"Pathway",72
"1726","TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling",0,"Pathway",72
"1727","TRAF6 mediated NF-kB activation",0,"Pathway",72
"1728","Trafficking and processing of endosomal TLR",0,"Pathway",72
"1729","Trafficking of GluR2-containing AMPA receptors",0,"Pathway",72
"1730","Trans-sulfuration and one carbon metabolism",0,"Pathway",72
"1731","Transcription",0,"Pathway",72
"1732","Transcription-coupled NER (TC-NER)",0,"Pathway",72
"1733","Transcription factor regulation in adipogenesis",0,"Pathway",72
"1734","Transcription of the HIV genome",0,"Pathway",72
"1735","Transcriptional activation by NRF2",0,"Pathway",72
"1736","Transcriptional activation of mitochondrial biogenesis",0,"Pathway",72
"1737","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer",0,"Pathway",72
"1738","Transcriptional regulation by small RNAs",0,"Pathway",72
"1739","Transcriptional regulation of white adipocyte differentiation",0,"Pathway",73
"1740","Transferrin endocytosis and recycling",0,"Pathway",73
"1741","Translation",0,"Pathway",73
"1742","Translation Factors",0,"Pathway",73
"1743","Translation initiation complex formation",0,"Pathway",73
"1744","Translocation of GLUT4 to the plasma membrane",0,"Pathway",73
"1745","Translocation of ZAP-70 to Immunological synapse",0,"Pathway",73
"1746","Transmembrane transport of small molecules",0,"Pathway",73
"1747","Transmission across Chemical Synapses",0,"Pathway",73
"1748","Transport of connexons to the plasma membrane",0,"Pathway",73
"1749","Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus",0,"Pathway",73
"1750","Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds",0,"Pathway",73
"1751","Transport of inorganic cations/anions and amino acids/oligopeptides",0,"Pathway",73
"1752","Transport of Mature mRNA derived from an Intron-Containing Transcript",0,"Pathway",73
"1753","Transport of Mature mRNA Derived from an Intronless Transcript",0,"Pathway",73
"1754","Transport of Mature mRNAs Derived from Intronless Transcripts",0,"Pathway",73
"1755","Transport of Mature Transcript to Cytoplasm",0,"Pathway",73
"1756","Transport of organic anions",0,"Pathway",73
"1757","Transport of Ribonucleoproteins into the Host Nucleus",0,"Pathway",74
"1758","Transport of the SLBP Dependant Mature mRNA",0,"Pathway",74
"1759","Transport of the SLBP independent Mature mRNA",0,"Pathway",74
"1760","Transport of vitamins, nucleosides, and related molecules",0,"Pathway",74
"1761","TRAP1",2,"Gene",81
"1762","TRAPPC10",0,"Gene",74
"1763","TRAPPC2L",0,"Gene",74
"1764","TRAPPC3",0,"Gene",74
"1765","Triacylglyceride Synthesis",0,"Pathway",74
"1766","TRIB3",48,"Gene",99
"1767","Triglyceride Biosynthesis",0,"Pathway",74
"1768","Trk receptor signaling mediated by PI3K and PLC-gamma",0,"Pathway",74
"1769","Trk receptor signaling mediated by the MAPK pathway",0,"Pathway",74
"1770","TRMT112",0,"Gene",74
"1771","tRNA Aminoacylation",0,"Pathway",74
"1772","Tryptophan metabolism",0,"Pathway",74
"1773","TSEN2",0,"Gene",74
"1774","TSH signaling pathway",0,"Pathway",74
"1775","TSLP Signaling Pathway",0,"Pathway",74
"1776","TSPAN4",0,"Gene",74
"1777","TSR3",0,"Gene",75
"1778","TUBA1A",17,"Gene",95
"1779","TUBB6",11,"Gene",92
"1780","TUFM",3,"Gene",82
"1781","TWEAK Signaling Pathway",0,"Pathway",75
"1782","TXNDC9",0,"Gene",75
"1783","TXNRD1",13,"Gene",93
"1784","TYMS",17,"Gene",95
"1785","Type I hemidesmosome assembly",0,"Pathway",75
"1786","Type II diabetes mellitus",0,"Pathway",75
"1787","Type II interferon signaling (IFNG)",0,"Pathway",75
"1788","U12 Dependent Splicing",0,"Pathway",75
"1789","UBC",173,"Gene",100
"1790","UBE2C",31,"Gene",98
"1791","Ubiquitin-dependent degradation of Cyclin D",0,"Pathway",75
"1792","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A",0,"Pathway",75
"1793","UBL5",0,"Gene",75
"1794","UBR2",4,"Gene",84
"1795","Unfolded Protein Response (UPR)",0,"Pathway",75
"1796","Unwinding of DNA",0,"Pathway",75
"1797","UQCRQ",5,"Gene",86
"1798","Urea cycle and metabolism of amino groups",0,"Pathway",75
"1799","Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling",0,"Pathway",75
"1800","USP22",2,"Gene",81
"1801","USP6NL",3,"Gene",82
"1802","UXS1",0,"Gene",75
"1803","Validated nuclear estrogen receptor alpha network",0,"Pathway",75
"1804","Validated nuclear estrogen receptor beta network",0,"Pathway",75
"1805","Validated targets of C-MYC transcriptional activation",0,"Pathway",75
"1806","Validated targets of C-MYC transcriptional repression",0,"Pathway",76
"1807","Validated transcriptional targets of AP1 family members Fra1 and Fra2",0,"Pathway",76
"1808","Validated transcriptional targets of deltaNp63 isoforms",0,"Pathway",76
"1809","Validated transcriptional targets of TAp63 isoforms",0,"Pathway",76
"1810","VAMP4",0,"Gene",76
"1811","Varenicline",447,"Compound",100
"1812","Vasopressin regulates renal water homeostasis via Aquaporins",0,"Pathway",76
"1813","VAV3",41,"Gene",99
"1814","VEGFA-VEGFR2 Pathway",0,"Pathway",76
"1815","VEGFR1 specific signals",0,"Pathway",76
"1816","VEGFR2 mediated vascular permeability",0,"Pathway",76
"1817","VEGFR3 signaling in lymphatic endothelium",0,"Pathway",76
"1818","Vif-mediated degradation of APOBEC3G",0,"Pathway",76
"1819","Viral Messenger RNA Synthesis",0,"Pathway",76
"1820","Viral mRNA Translation",0,"Pathway",76
"1821","Vitamin A and Carotenoid Metabolism",0,"Pathway",76
"1822","Vitamin B1 (thiamin) metabolism",0,"Pathway",76
"1823","Vitamin B12 Metabolism",0,"Pathway",76
"1824","Vitamin D Metabolism",0,"Pathway",76
"1825","VLDLR",3,"Gene",82
"1826","Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization",0,"Pathway",76
"1827","Vpr-mediated nuclear import of PICs",0,"Pathway",77
"1828","Vpu mediated degradation of CD4",0,"Pathway",77
"1829","vRNP Assembly",0,"Pathway",77
"1830","WASF3",7,"Gene",89
"1831","WDR37",0,"Gene",77
"1832","WIPF1",5,"Gene",86
"1833","WNT mediated activation of DVL",0,"Pathway",77
"1834","Wnt signaling network",0,"Pathway",77
"1835","Wnt Signaling Pathway",0,"Pathway",77
"1836","Wnt Signaling Pathway and Pluripotency",0,"Pathway",77
"1837","Wnt Signaling Pathway Netpath",0,"Pathway",77
"1838","WNT5A-dependent internalization of FZD2, FZD5 and ROR2",0,"Pathway",77
"1839","WNT5A-dependent internalization of FZD4",0,"Pathway",77
"1840","WRB",0,"Gene",77
"1841","XBP1(S) activates chaperone genes",0,"Pathway",77
"1842","Xenobiotics",0,"Pathway",77
"1843","XRCC6",21,"Gene",96
"1844","YAP1- and WWTR1 (TAZ)-stimulated gene expression",0,"Pathway",77
"1845","YARS2",3,"Gene",82
"1846","YBX3",2,"Gene",81
"1847","YME1L1",0,"Gene",77
"1848","YTHDF1",0,"Gene",77
"1849","ZBP1(DAI) mediated induction of type I IFNs",0,"Pathway",77
"1850","ZBTB48",0,"Gene",78
"1851","ZEB2",2,"Gene",81
"1852","ZNF248",2,"Gene",81
"1853","ZNF516",0,"Gene",78
"1854","ZNF518A",0,"Gene",78
"1855","ZNHIT1",0,"Gene",78
"1856","ZWINT",9,"Gene",91
